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ABSTRACT

ASSESSING PHYSICAL THERAPY OUTCOMES FOR WOMEN WITH
URINARY INCONTINENCE

By
Jodi Dusi
May 2011

Dissertation supervised by Diane Borello-France, PT, PhD
The purpose of this study was to 1) determine the efficacy of physical therapy
interventions to reduce pelvic symptoms and improve health-related quality of life and
global impression of improvement in women with urinary incontinence; 2) determine the
relationship between selected patient-related characteristics and treatment success; and 3)
describe interventions utilized to manage the care of women with urinary incontinence.

Methods: A pragmatic study design was used to explore study aims. The physical therapy
records of 100 female patients with urinary incontinence from Centers for Rehab
Services provided data for this study. Data from routine clinical care was entered into an
electronic database designed for quality improvement purposes. Outcome measures to
determine improvements in pelvic symptoms and health-related quality of life included
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the Pelvic Floor Distress Inventory-20 (PFDI-20) and Pelvic Floor Impact Questionnaire7 (PFIQ-7), respectively. Global impression of improvement was recorded using the
Patient Global Index of Improvement (PGI-I) administered post-intervention. The
relationships between patient-related characteristics and treatment success were explored
using logistic regression. Descriptive statistics were utilized to describe the interventions
received by women.

Results: Mean pre- to post-intervention PFDI-20 and PFIQ-7 scores were significantly
reduced indicating that women’s pelvic symptoms and health-related quality of life
improved following physical therapy intervention. The median PGI-I score was “2”
indicating symptoms were “much better” following intervention. Sixty-six percent of
women met the study criteria for PGI-I defined treatment success. Women who achieved
treatment success had a lower mean age (51.86±15.59 vs. 59.29±13.15 years) and had
more physical therapy visits (9.05±5.51 vs. 5.74±2.55 visits) than those who did not
perceive symptom improvement. Additionally, the distribution of the occurrence of
barriers between women who did and did not perceive treatment success was different
than would be expected by chance. When age, presence of barriers to intervention
recommendations, and number of physical therapy visits were entered into the logistic
regression model, only barriers to intervention recommendations (OR 12.82; 95% CI
4.05-40.55) and number of physical therapy visits (OR 1.26; 95% CI 1.07-1.50) were
influential in predicting PGI-I outcome. Women in the study received a combination of
treatments including education, exercise, modalities, and manual procedures.
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Chapter 1
Introduction
1.1 Background
Urinary incontinence (UI) is defined by the International Continence Society as
an “involuntary loss of urine which is objectively demonstrable and a social or hygienic
problem.”1 UI affects approximately 20 million people in the United States2 with
economic costs of over $16 billion per year.2 Moreover, UI leads to social isolation,3
poor self-rated health,4 decreased quality of life,5 and depressive symptoms.6 Physical
therapists are involved in the clinical management of female UI because the impairments
that these women demonstrate (i.e. decreased pelvic floor muscle strength; decreased
endurance and/or coordination; and decreased awareness of lifestyle factors that
contribute to UI) fall within the scope of physical therapy practice according to the Guide
to Physical Therapist Practice.7 Consequently, there is a growing need to understand the
efficacy of physical therapy interventions aimed toward reducing female UI symptoms
and improving the quality of life.
There are three main types of UI – stress, urge, and mixed. Stress urinary
incontinence (SUI) is the complaint of involuntary leakage on effort or exertion, or on
sneezing or coughing.1 Urge urinary incontinence (UUI) is the complaint of involuntary
leakage accompanied by or immediately preceded by urgency.1 Mixed urinary
incontinence is the complaint of involuntary leakage associated with urgency and also
with exertion, effort, sneezing or coughing.8
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SUI may develop from loss of structural support of the bladder or bladder neck
which includes damage to the pelvic floor muscles,9 endopelvic fascia,10 or pudendal
nerve.9 Conservative physical therapy interventions for SUI includes pelvic floor muscle
exercises11-18 which may improve urethral closure19, 20 and pelvic organ support.21, 22
Some women with SUI have difficulty contracting their pelvic floor muscles. In these
women, biofeedback18, 23-26 or electrical stimulation16, 26 may be utilized to augment
pelvic floor muscle training.
UUI is a symptom of Overactive Bladder (OAB) syndrome which is characterized
as urinary urgency with or without urge incontinence, as well as nocturia and urinary
frequency (urinating more often than usual).27 OAB may be attributed to structural
bladder changes that occur with age9, 28 pelvic organ prolapse,9 or neurological diseases
that decrease the parasympathetic control of the bladder.9 There are two general
approaches to the management of UUI. The first, behavioral training, includes pelvic
floor muscle (PFM) exercises to inhibit bladder contractions and other urge suppression
strategies. The second approach, bladder training, focuses on restoring normal bladder
function by modifying bladder habits using structured voiding schedules.29
It is common for women with UI to have co-existing pelvic symptoms, including
bowel (constipation or incontinence) and/or pelvic organ prolapse (bladder, bowel, and/or
uterine). In addition, women may complain that their pelvic symptoms impact sexual
function. Co-existing UI and fecal incontinence rates of 18-31%30-32 are reported, while
the prevalence of co-existing constipation and UI in women ranges from 31-36%.33, 34
Moreover, Ellerkmann and co-workers reported that 86% of women with pelvic organ
prolapse had urinary urgency and frequency.30 In addition, women with urinary
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symptoms have a 4-fold higher risk for sexual arousal dysfunction and a 7-fold higher
risk for sexual pain with intercourse than women without urinary symptoms.35
Clinicians believe that physical therapy interventions may improve bowel, pelvic
organ prolapse, and/or sexual function symptoms. The most common interventions for
constipation include increasing fluid intake, increasing dietary fiber intake, and
promoting bowel motility via abdominal massage.36-39 Limited research has been done
investigating the efficacy of abdominal massage. However, one published case report
documented the effectiveness of abdominal massage to restore normal bowel frequency
in a female client with constipation after only five physical therapy visits.40
Physical therapy interventions for fecal incontinence include PFM exercise,
biofeedback, and electrical stimulation.41 PFM exercise with biofeedback has been shown
to improve bowel symptoms,42 but there is a limited number of trials investigating the
added effect of biofeedback with PFM training.43 Electrical stimulation has not been
shown to be effective in the small number of clinical trials investigating its use for
women with fecal incontinence.42, 44 Recent practice guidelines by the American College
of Gastroenterology suggest that electrical stimulation should be considered experimental
and merits investigation within controlled clinical trials.45
Women seldom seek physical therapy solely for sexual dysfunction or pelvic
organ prolapse symptoms. Typically these symptoms and limitations accompany UI and
are identified during the patient history and/or systems review. Consequently, few
clinical studies have been performed that have examined the efficacy of physical therapy
interventions for pelvic organ prolapse and sexual dysfunction. Thus, one primary aim of
this study was to determine the efficacy of physical therapy interventions provided within
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a pragmatic setting on global impression of improvement, pelvic symptoms, and healthrelated quality of life to women with UI.
Although separate interventions exist for bowel and bladder dysfunction, there are
no published reports describing the efficacy of physical therapy interventions for women
with UI and co-existing pelvic dysfunctions. Urinary, bowel, prolapse, and sexual
dysfunction conditions are associated with damage to the pelvic floor either through
mechanical disruption of connective tissue, or through direct and secondary muscle or
nerve injury. Because urinary, bowel, prolapse, and sexual dysfunction conditions share
common etiologies and risk factors,46 it is reasonable to speculate that physical therapy
interventions aimed toward reducing UI will also contribute, along with other symptomspecific (bowel, prolapse, sexual dysfunction) interventions, to the reduction of coexisting bowel, prolapse, and/or sexual dysfunction symptoms.
Physical therapy interventions may not be equally beneficial to all women who
seek treatment for UI and other pelvic floor disorders. Certain patient-related
characteristics may be associated with poorer intervention outcomes. The number and/or
type of risk factors a woman has for UI may be associated with poor physical therapy
outcomes. Identified risk factors for UI include: age;47-50 childbirth;48, 51-54 Caucasian
race;48, 49, 55 smoking;56, 57 daily or greater consumption of carbonated drinks;57 number
of comorbidities; and presence of barriers to intervention recommendations.
Comorbidities refer to diseases or health conditions (as defined by the World Health
Organization58) that are associated with UI and include: obesity;48-50, 57, 58 respiratory
disease/chronic cough;59-61 pelvic surgery;48, 60-63 bowel dysfunction (chronic
constipation;53, 60-62 fecal incontinence;32, 33, 64 irritable bowel syndrome65); pelvic organ

4

prolapse;30 pain (pelvic pain61, 66 and low back pain67); neurological conditions;9, 60 and
diabetes.9, 60 Barriers to intervention recommendations refer to the patient’s physical
impairments, such as profound muscle weakness or sensory deficits that have the
potential to impact the effectiveness of physical therapy interventions as well as personal
barriers that prevent adherence to the physical therapist’s recommendations for exercise,
change in urinary/bowel habits, and/or other lifestyle modifications. In addition, the
number of physical therapy visits a woman attends may also influence physical therapy
outcomes. According to a recent systematic review, treatment effect may be greater in
women with SUI who received a longer duration of PFM training (6 months versus 8
weeks).17 Given the possible influence of patient-related characteristics on physical
therapy outcomes, the second primary aim of this study was to determine the association
between patient-related factors (selected risk factors for UI, selected comorbidities,
barriers to intervention recommendations, and number of physical therapy visits
attended) and physical therapy treatment outcomes.
Although physical therapy treatment interventions utilized in the management of
women with UI have been well described (including PFM training,11, 13-18, 20, 22, 68-70 core
stabilization training,71, 72 and patient education22, 73-76), there are no published reports
describing treatment interventions for women with UI and concomitant pelvic symptoms
(bowel, prolapse, and/or pelvic pain). To describe the current physical therapy practice
trend for women with various pelvic symptoms, it would be useful to gather such
information from multiple physical therapists in a pragmatic setting. Consequently, the
secondary aim of this study was to describe the interventions applied by physical
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therapists to manage the care of women with UI and those with UI and coexisting bowel,
prolapse, and pelvic pain symptoms.

1.2 Operational Definitions
Global impression of improvement. The patient’s global perception of improvement with
physical therapy intervention was measured and defined as the post intervention Patient
Global Impression of Improvement (PGI-I) 77 score. The PGI-I was used as a primary
outcome measure in this study. The PGI-I includes one question that asks the respondent
to compare their condition now (at discharge) as to how it was prior to starting physical
therapy. The PGI-I response range is 1-7, with 1 being “very much better” and 7 being
“very much worse.” Thus, the lower the post-intervention PGI-I score, the more
improved the patient perceives her condition following physical therapy intervention. In
this study, treatment success is defined as a post-intervention PGI-I score of 2 indicating
“much better” or 1 indicating “very much better.”
Pelvic symptoms. Three assessment instruments were used to measure pelvic symptoms
associated with UI, bowel dysfunction, pelvic organ prolapse, and sexual dysfunction.
Each assessment instrument was administered to subjects pre-and post intervention. The
first instrument was the Pelvic Floor Distress Inventory (PFDI-20)78 which was used as
one of the primary outcome measures in this study. The PFDI-20 has a score range from
0-300 with lower scores indicating fewer pelvic symptoms and symptom distress
associated with urinary, bowel, and pelvic organ prolapse. Thus, pre-post intervention
changes to lower PFDI-20 scores indicate improvement in pelvic symptoms. The two
remaining assessment instruments measuring pelvic symptoms were secondary outcome

6

measures in the study and included the Constipation Scoring System (CSS)79 and the pain
subscale of the Female Sexual Function Index (FSFI).80 The CSS assesses constipation
symptoms while the pain subscale of the FSFI measures pain with sexual intercourse.
The range of CSS scores is 0-30, with higher scores indicating greater constipation
symptoms. Thus, pre-post intervention changes to lower CSS scores indicate
improvement in constipation symptoms. The range of scores for the FSFI subscale is 0-6,
with a higher score indicating greater reduction in pain associated with sexual
intercourse. Thus, pre-post intervention changes to higher scores indicate reduced sexual
pain with intercourse.
Health-related quality of life. Health-related quality of life was measured by the Pelvic
Floor Impact Questionnaire (PFIQ-7)78 and the PFIQ-7 will was used as a primary
outcome measure in this study. The PFIQ-7 has a score range from 0-300, with lower
scores indicating better perceived health-related quality of life.78 PFIQ-7 scores were
obtained from patients pre- and post-intervention. Thus, pre-post intervention changes to
lower PFIQ-7 scores indicate improved health-related quality of life.
Barriers to intervention recommendations. – Barriers to intervention recommendations
refer to occurrences during the physical therapy intervention phase that have potential to
interfere with the patient achieving improvements in pelvic symptoms, health-related
quality of life, and/or global impression of improvement. Specific barriers recorded by
the physical therapist during intervention included any of the following: a) patient did not
attend all recommended physical therapy visits; b) patient was not adherent to home
exercise program; c) patient did not adhere to recommended lifestyle modifications; d)
cognitive impairments interfered with patient’s ability to follow the plan of care; e)
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comorbidities contributed to UI or interfered with the patient’s ability to follow the plan
of care; f) medications contributed to UI, limiting outcomes; g) sensory loss limited
patient’s ability to recognize correct muscle contraction; and h) profound muscle
weakness/muscle denervation limited potential for increase muscle function.

1.3 Limitations and Assumptions
1. A change score of 11 points on the PFDI-20 and 16 points on the PFIQ-7 was
considered a minimum important difference81 for women with UI seeking physical
therapy services.
2. Pre-to post-intervention score differences were attributable to the physical therapy
interventions.
3. Patients completed the PGI-I, PFDI-20, PFIQ-7, CSS, and FSFI questionnaires
accurately and honestly.
4. Patients may have failed to return all outcome questionnaires to the physical therapists
contributing to missing data.
5. Physical therapists entered the data into the database accurately and honestly.
6. Physical therapists may have failed to enter data on all patients contributing to a
smaller sample for analysis than projected. The ability to enter data on patients was
linked to the computerized billing system. Data entry was not possible after an account
was closed.

1.4 Delimitations
1. Data from 100 women were analyzed.
8

2. Fifteen physical therapists from twelve physical therapy sites entered data into the
database.
3. The physical therapists provided input throughout the selection of outcome measures,
standardization of forms/assessment procedures, and creation of database which assisted
in maximizing compliance by the physical therapists.
4. The last documented data was used in the final analyses when data was missing.
5. Physical therapists were reminded monthly to enter data on all patients with UI in a
timely manner.
6. Patients that did not return outcome questionnaires during their final physical therapy
visit were asked to return them via postal mail.

1.5 Problem Statement
This study proposed the following primary aims:
a) To determine the efficacy of physical therapy interventions provided within a
pragmatic setting on global impression of improvement, pelvic symptoms, and healthrelated quality of life to women with UI.
b) To determine the relationship between selected patient-related characteristics (age,
parity, race, number of comorbidities, carbonated beverage intake, current smoking
status, presence of barriers to intervention recommendations, and number of physical
therapy visits) and treatment success. Treatment success was defined as a postintervention PGI-I score of “much better” or “very much better;” a reduction in pelvic
symptoms (reduction in PFDI-20 score at discharge) and improvement in health-related
quality of life (reduction in PFIQ-7 at discharge).
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The secondary aim was to document the percentage of women who received 4
possible interventions. Because intervention selection may be determined by the
constellation of symptoms a woman possesses, separate percentages were calculated for 4
symptom-based categories of women. The categories included: UI symptoms only, UI +
bowel symptoms, UI + pelvic pain, or UI + bowel symptoms + pelvic pain. Interventions
included patient education, modalities, manual physical therapy procedures, and exercise.

1.6 Independent Variables
1. Treatment Intervention – Because this is not an experimental trial, the treatment
interventions included those chosen by the physical therapists to manage the patients’
care. However, the treatment intervention was categorized into one or more of the
following categories:
a. Patient Education: Patient education is determined by the physical therapist and may
include education in body mechanics/posture; bladder/bowel schedule; diet modification
(caffeine reduction, carbonated beverage reduction, fluid management [increase or
decrease water intake as appropriate], and/or fiber intake (increase or decrease fiber as
appropriate); relaxation techniques such as diaphragmatic breathing or progressive
relaxation; SUI strategies (pelvic floor muscle contraction prior to activity that increases
intra-abdominal pressure such as lifting or sneezing); UUI strategies (pelvic floor muscle
contraction to decrease urgency and delay voiding); toilet strategies for constipation
(appropriate toilet posture to promote bowel movement) and to void without straining;
and soft tissue massage (abdominal massage for constipation, scar massage, or selfstretching of the vaginal introitus).
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b. Modalities: The following modalities may be included in the physical therapy plan of
care: biofeedback (to promote pelvic floor muscle strength and endurance, to increase
pelvic floor muscle coordination, and/or to promote pelvic floor muscle relaxation)
electrical stimulation (to improve pelvic floor muscle strength, to promote sensory
awareness of the pelvic floor muscles, and/or to reduce pelvic pain), and heat/cold to
reduce pelvic pain.
c. Manual physical therapy procedures: Manual physical therapy procedures may include
soft tissue mobilization to decrease soft tissue restrictions and improve range of motion;
and joint mobilization to improve joint range of motion.
d. Therapeutic exercises: Therapeutic exercises include PFM exercise to promote pelvic
floor muscle strength, relaxation, and/or coordination (with manual intra-vaginal
facilitation; in gravity eliminated or anti-gravity positions; or during functional tasks);
trunk stabilization exercises to improve strength of the transverse abdominus, other
abdominal muscles, multifidus, and/or to promote trunk stabilization during functional
activities such as lifting; and flexibility exercises to increase mobility of the hip and/or
lumbopelvic regions.
2. Patient-related characteristics with 8 sublevels: Patient-related characteristics include
age (years), parity (nulliparous or parous), race (Caucasian or non-Caucasian), number of
comorbidities (0-8), carbonated beverage intake (> 1 per week or <1 per week), current
smoking status (smoker or non-smoker), presence of barriers to intervention
recommendations (none or ≥1), and number of physical therapy visits.
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1.7 Dependent Variables
The present study investigated three primary outcomes:
1. The post-intervention PGI-I score.
2. The difference between pre-intervention and post intervention values on the PFDI-20.
3. The difference between pre-intervention and post intervention values on the PFIQ-7.
As not all women represented in this study will experience bowel symptoms and/or
sexual dysfunction, the present study also investigated two secondary outcomes:
1. The difference between pre-intervention and post intervention values on the CSS.
2. The difference between pre-intervention and post intervention values on the FSFI.

1.8 Hypothesis
Data collected for this study was used to test one specific hypothesis:
Women with UI receiving pragmatic physical therapy management will attain treatment
success. Treatment success is defined as a post-intervention PGI-I score of “much better”
or “very much better;” a reduction in pelvic symptoms (reduction in PFDI-20, FSFI, and
CSS scores at discharge) and improvement in health-related quality of life (reduction in
PFIQ-7 at discharge).
As the remaining study aims are descriptive in nature, no specific hypotheses for these
aims are stated.
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Chapter 2
Review of Literature
2.1 Introduction
Urinary incontinence (UI) is defined by the International Continence Society as a
“involuntary loss of urine which is objectively demonstrable and a social or hygienic
problem.”1 There are three main types of urinary incontinence – stress, urge, and mixed.
Stress urinary incontinence (SUI) is the complaint of involuntary leakage on
effort or exertion, or on sneezing or coughing.1 During effort or exertion, the intraabdominal pressure is raised and the urethral sphincter is unable to maintain a pressure
higher than that exerted on the bladder. Subsequently, urine leakage occurs during
everyday activities such as lifting, laughing, jumping, sneezing, or coughing.
Urge urinary incontinence (UUI) is the complaint of involuntary leakage
accompanied by or immediately preceded by urgency.1 During bladder filling, the
bladder contracts abnormally which creates a sensation to urinate that becomes
progressively stronger, is very difficult to ignore, and ultimately results in urine leakage.
UUI may be associated with overactive bladder syndrome (OAB). OAB is a symptom
syndrome denoting urgency, frequency, and nocturia, with or without UUI.8
Urodynamically, OAB can be described as involuntary detrusor contractions during the
filling phase.9 Literature investigating OAB with UUI is relevant in the discussion of UUI
because OAB can produce contractions of the bladder that may contribute to UUI.
Finally, mixed urinary incontinence is the complaint of involuntary leakage associated
with urgency and also with exertion, effort, sneezing or coughing.8 UI affects
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approximately 20 million people in the United States2 and the prevalence of UI in women
ranges from 26-46%.5, 54, 60, 82 Of women reporting UI, women complain of mixed
urinary incontinence most often (50-56%),2, 83 followed by SUI (33-27%)2, 83 and UUI (913%).2, 83 In addition, women experience an age-related increase in prevalence of UI with
67% of post-menopausal women reporting unintentional urine leakage.59
The economic costs of UI are substantial comprising over $16 billion per year in
the United States. Most of the cost is attributed to resources for UI management such as
absorbent pads, protection, and laundry.2 Subak and colleagues reported that communitydwelling women spend nearly $750 per year out of pocket for incontinence management.
Nearly 85% of the women reported absorbent pad use, 50% of women reported additional
loads of laundry due to UI, and 14% reported additional dry cleaning each week due to
UI.84 Incontinence costs increase with more frequent UI episodes.12, 13 Those with severe
and very severe incontinence encounter a 2-fold greater cost than women with slight
incontinence.82 Moreover, women were willing to pay more for greater reduction in UI
episode frequency82, 84 from a mean of $31 per month for 25% reduction, to $44 for 50%
reduction, and $118 for 100% reduction.84
UI also leads to social isolation,3 poor self-rated health,4 decreased quality of life,5
and depressive symptoms.6 Subak and colleague found women with UI scored
substantially lower on the Health Utilities Index (mean score of 0.73)84 compared to the
women aged 45 years and older with no chronic medical conditions (mean = 0.92). The
Health Utilities Index utility measures global health-related quality of life on a scale from
-0.36 to 1.0, where -0.36 is the worst possible state, 0 is associated with death, and 1.0 is
the best attainable health. 85, 86
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Fultz and colleagues asked community dwelling women with UI to indicate the
degree to which they found their leakage to be bothersome on a scale of 1 to 5 where 1 is
“not at all bothersome” and 5 is “extremely bothersome.”87 About half of the women
were slightly bothered and 30% were moderately to extremely bothered by their
symptoms. Those that were moderately to extremely bothered reported that their UI had
a negative impact on physical activity, confidence, daily activities, and social activities87
indicating that UI affects more domains than simply health-related quality of life.
Additionally, quality of life scores appear to diminish with increasing levels of UI
frequency. Ragins and colleagues demonstrated that an increase in UI frequency (e.g.
from less than monthly to monthly incontinence, from weekly incontinence to daily
incontinence) is significantly associated with a decrease in quality of life as reported on
the SF-36 and Incontinence Impact Questionnaire in women aged 40-69.88 In addition,
increased UI frequency has been shown to be associated with increased bothersomeness
of symptoms.5, 87 Moreover, self-assessed health, sleep, fitness and satisfaction with
work situation has been shown to decrease significantly with increased frequency of UI
in women aged 20-59.89
UI is an important problem faced by many women that affects their mental and
physical well-being as well as their function in society. Physical therapists have become
involved in the clinical management of UI in women because the presumptive underlying
impairments (i.e. decreased pelvic floor muscle strength and/or endurance, decreased
awareness of bladder irritants) fall within the scope of physical therapy practice
according to the Guide to Physical Therapist Practice.7 Consequently, there is a growing
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need to understand how physical therapy interventions impact women’s UI symptoms,
impairments, and functional limitations.

2.2 Mechanism of UI
2.2.1 Anatomic
The continence mechanism is embedded within the pelvic floor therefore, it is
necessary to define the three layers (deep to superficial) of the pelvic floor structure:
endopelvic fascia, levator ani muscle (LA), and the perineal membrane or external anal
sphincter.90 The endopelvic fascia attaches the cervix and vagina to the pelvic wall on
each side of the pelvis dividing the pelvis into an anterior and posterior compartment
(Figure 2.1). This continuous sheet-like mesentery extends from the uterine artery
superiorly to the point at which the vagina fuses with the LA below as well as fanning
laterally.91 Subsequently, the fascia is intimately associated with the pelvic organs as well
as the second layer of the pelvic floor, the LA. The LA is a muscle made up of several
smaller muscles that function as a group (Figure 2.2).90 The iliococcygeal and coccygeal
portions form a horizontal shelf or hammock that spans from one pelvic sidewall to the
other, attaching laterally to the ischial spines and arcus tendineus fascia. The
pubococcgeus arises from the pubic bone on either side and extends into a sling or Ushape around the posterior rectum, attaching to the walls of the vagina, urethra, and
rectum.91 The opening between the LA through which the urethra, vagina, and rectum
pass is the urogenital hiatus. The urogenital hiatus is supported by the pubic bones and
LA anteriorly and by the perineal membrane and external anal sphincter posteriorly.91
The perineal membrane is a dense triangular membrane located below the LA with a
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central opening through which the vagina and urethra pass.90, 91 The final member of the
third layer is the external anal sphincter.

Endopelvic Fascia

Figure 2.1 Endopelvic fascia
overlying Levator Ani

Figure 2.2 Inferior to superior
view of the pelvic floor
musculature

The anatomy of the continence system can be organized into those structures that
provide normal support to the lower urinary tract, and those that determine urethral
closure force. The structures providing normal support include the 3 layers of the pelvic
floor discussed previously. Structures that determine urethral closure force include the
internal and external urethral sphincters and mucosal vasculature.91 The continence
system works to maintain closure of the urethral lumen. At the vesical neck, the lumen is
held closed by the trigonal ring and detrusor loop muscles which are smooth, involuntary
muscles controlled by alpha-adrenergic receptors of the sympathetic nervous system.
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During bladder storage, activation of the sympathetic nervous system increases the tonic
activity or the internal urethral sphincter to assist in preventing urine leakage. The
external urethral sphincter encircles the urethra in its midportion and distally the fibers
diverge to insert in the walls of the vagina and the perineal membrane. The external
urethral sphincter is constantly active promoting closure of the urethral lumen.91

2.2.2 Neurophysiologic
Urinary continence is maintained by an intimate relationship involving anatomical
support as well as neurophysiology. The lower urinary tract is innervated by 3 sets of
peripheral nerves: pelvic parasympathetic nerves (S2-S4 segments) which excite the
bladder; lumbar sympathetic nerves which inhibit the bladder and excite the internal
urethral sphincter; and the pudendal nerves which excite the external urethral sphincter
and pelvic floor muscles.92 As the bladder fills with urine, there is little change in the
intravesical pressure due to viscoelastic properties of the bladder smooth muscles. As
filling continues, the β-receptors in the body of the bladder (causing relaxation) and the
α-receptors in the bladder neck (causing contraction) are stimulated. This sympathetic
stimulation also inhibits the parasympathetic nerves to prevent excitation of the bladder.
As bladder filling progresses, somatic discharge to the pudendal nerve increases. This
leads to increased activity in the external urethral sphincter and effective urethral
closure.92
Voiding is initiated by relaxation of the urethral sphincters followed by bladder
contractions. When the bladder contracts, there is decreased α-adrenergic stimulation of
the bladder neck which promotes a funnel appearance of the bladder neck. The bladder

18

contraction is divided into 2 phases: a short, rapid rise in intravesical pressure and a
second prolonged period of maintained pressure in which the bladder empties. Voiding
involves coordination of parasympathetic efferent stimulation of the bladder, inhibition of
sympathetic outflow, and inhibition of pudendal somatic outflow to the external urethral
sphincter.92

2.3 Pathophysiology of SUI
The main anatomic hypotheses for development of SUI include loss of structural
support and the hammock hypothesis.9 Supportive structures to the bladder neck and
urethra are necessary to maintain urethral closure pressure. Intact attachments of the
suburethral fascia to the fascia of the arcus tendineus and the LA construct the firm shelf
that remains stable when faced with increased forces generated by a cough or sneeze.90
Disruption to this shelf, such as weakness to LA or damage to fascial attachments could
result in UI. Aging and childbirth injury are the main etiological factors for LA weakness.
When the LA is weak, the urethra is shifted to a lower, more dependent position. Thus,
increased intra-abdominal pressure during a cough or sneeze is then transmitted
unequally to the bladder and urethra. Greater pressure is absorbed by the bladder,
bladder pressure exceeds urethral pressure, and urine leakage occurs.9
In the hammock hypothesis, the position of the urethra remains constant but there
is decreased compression of the pelvic floor muscles and fascia supporting the urethra.
During anatomic dissection, DeLancey reported that the urethra lies on a supportive layer
comprised of endopelvic fascia and the anterior vaginal wall. Stability of the layer is
gained via lateral attachment to the arcus tendineus fascia pelvis and levator ani muscle.
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In an intact support system, intra-abdominal pressure pushes the urethra against the
hammock-like supportive layer and the urethral lumen closes, not allowing urine to pass.
However, if the supportive layer is not intact, the lumen will not close completely,
resulting in urine leakage.10
The main neural hypothesis for development of SUI is pudendal nerve injury. The
pudendal nerve innervates the external urethral sphincter. Injury to the nerve presumably
causes denervation and dysfunction of the urethra including decreased urethral resistance
and SUI.9 Damage to the pudendal nerve is associated with recent vaginal delivery and
SUI. In a study of pregnant women, vaginal delivery resulted in prolonged pudendal
nerve terminal motor latencies in 89/128 women.93 It has been suggested that pudendal
nerve damage persists over time. Significantly higher pudendal nerve terminal latencies
have been observed in multiparous women with vaginal births both 48 hours and 5 years
after delivery compared with nulliparous controls. Moreover, 35% of these women had
developed SUI over the 5 year period.94

2.4 Risk Factors for SUI
2.4.1 Childbirth
Considering that loss of structural support is a main etiological factor in SUI, it is
not surprising that parity is associated with SUI. Waetjen and colleagues reported that
childbearing women were nearly twice as likely to report SUI compared to nulliparous
women (OR 1.91; 95% CI 1.31-2.79). 54 Minassian demonstrated that parity was a
significant independent risk factor for moderate and severe SUI. Women with moderate
and severe SUI were 2.7 (adjusted OR 2.79; 95% CI 1.48-5.29 for moderate SUI and
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adjusted OR 2.74; 95% CI 1.41-5.31 for severe SUI) times more likely to report history
of childbirth compared to women without incontinence.48 Furthermore, women who
have delivered more than one child are at higher risk for SUI than women who delivered
only one child. Schytt and colleagues reported a higher risk for SUI in multiparous than
in primiparous women (RR 1.3; 95% CI 1.1-1.5).53 Similarly, Pregazzi and colleagues
reported that the prevalence of SUI in multiparous women was significantly higher than
primiparous women (20.25% versus 8.18%, P=0.0001).51
Regarding mode of delivery, there is an increase risk for SUI with vaginal
delivery, but a cesarean section does not completely protect against UI. Schytt53 and
Rortveit95 reported that women having a vaginal delivery were two times more likely to
report SUI compared to those who delivered via cesarean section (RR 2.2; 95% CI 1.63.153 and OR 2.4; 95% CI 1.7-3.295 respectively). However, in Rortveit’s and Schytt’s
studies, 7% and 10% of the women who delivered by cesarean section reported SUI
respectively. The presence of SUI in the absence of the mechanical trauma of vaginal
delivery suggests that other factors during pregnancy may contribute to the development
of SUI and those with cesarean delivery are also at risk for SUI. Borello-France reported
that women who delivered by cesarean section had similar prevalence rates for SUI
compared to those with vaginal births at both 6 weeks and 6 months post-partum.12 When
compared to no deliveries, both vaginal deliveries and cesarean sections were associated
with higher rates of SUI (OR 3.0; 95% CI 2.5-3.5 and OR 1.4; 95% CI 1.0-2.0
respectively) in the age-adjusted analysis of 15,307 women participating in the
EPINCONT (Epidemiology of Incontinence in the Country of Nord-Trondelag) study.51
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Consequently, it appears that women who have had vaginal deliveries or women who
have had cesarean sections are at risk for SUI.

2.4.2 Age
Although prevalence of any UI increases with age, the trend varies in regard to
type of UI. In a national survey of a representative sample of US women, Minassian,
Walter, and Wood reported that prevalence of SUI peaked in the fifth decade of life and
gradually decreased with older age in women.48 This is similar to Hannestad and
colleagues who demonstrated that SUI symptoms were highest among women between
25 and 49 years of age, with subsequent relative decrease with increasing age.47
Minassian also investigated risk factors separately for women with mild, moderate, and
severe UI, where severity was defined by frequency of incontinent episodes. For those
with moderate SUI, age was a significant risk factor from age 40+.48 Hannestad reported
that among those with severe SUI, severity increased with age from 10% of women aged
25-44 reporting severe SUI compared to 15% and 33% reporting severe symptoms in age
groups 45-59 and 60+, respectively.47

2.4.3 Decreased Collagen & Decreased Elasticity
It is believed that dysfunction of connective tissue in the endopelvic fascia or pelvic
ligaments may lead to loss of structural support of the pelvic organs, and subsequently
SUI. Connective tissue is comprised of collagen and elastin fibers, ground substance,
and cellular substances. Collagen primarily provides strength, but may also provide some
flexibility due to collagen fiber arrangement. Elastin weaves in and out of the collagen
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fibers and primarily provides flexibility. Elastin fibers follow the direction of stretch in
tissues and once the stretching force is removed, assume their original shape.
Investigators have demonstrated altered morphological features and decreased
collagen content in women with SUI. FitzGerald and colleagues demonstrated frequent
alterations in the ultrastructural morphological characteristics of urethral collagen in 9 of
the 15 women with SUI consenting to urethral needle biopsy specimens.96 The collagen
patterns differed from those observed in continent women. Observations included an
obscured pattern where collagen fibrils were difficult to visualize, a dense pattern in
which collagen fibrils appeared to be collapsed on one another, and a degenerative
pattern in which collagen fibrils were rare.96 Differences in cervical collagen between
continent and incontinent women has also been reported. Wong and colleagues compared
cervical collagen from women with pelvic organ prolapse with and without SUI (who
underwent hysterectomy) to that from a control group.97 Women with pelvic organ
prolapse with and without SUI were found to have significantly less cervical collagen
than their unaffected counterparts.97

2.4.4 Race/Ethnicity
The few studies that have compared the prevalence of UI in women of different
ethnicities have demonstrated an increased risk for Caucasian women. Sampselle and
colleagues reported that Caucasian women were more likely to report UI compared to
African American, Chinese, Hispanic, and Japanese women in cross-sectional study of
3302 women.55 Using prevalence in Caucasian women as the reference, women of other
ethnicities were approximately two to three times less likely to report any incontinence.

23

When taking account subsets of UI, there appears to be a greater association between
Caucasian race and SUI. After adjusting for age, BMI, parity, hormone replacement,
smoking, and medical history, a cross-sectional study of 2875 women found that
Caucasian women had an increased risk for SUI compared to African American
women.48 Additionally, a study of 2763 postmenopausal women found that Caucasian
women had a threefold greater prevalence of SUI than postmenopausal black women (OR
2.9, 95% CI 1.6-5.0).59

2.4.5 Obesity
Many studies have found that obesity is associated with increasing rates of SUI.
In a study of postmenopausal women, Brown and colleagues reported that a higher body
mass index (OR 1.1 per 5 units; CI 1.01-1.27) was associated with increased prevalence
of SUI.59 Additional studies, cross-sectional and longitudinal, have demonstrated an
association with obesity and SUI. In a large study of 12570 women, women who were
overweight (BMI >25-30) or obese (BMI >30) had a significantly higher risk for SUI
(OR 1.2; 95% CI 1.0-1.5 and OR 1.7; 95% CI 1.4-2.1 respectively). Women who had an
acceptable BMI at baseline but became obese one year later were 2.3 times more likely to
develop SUI.50 Similarly, a 1-yr longitudinal study of 7046 UK women found, those who
became obese (BMI >30) in 1-yr were 1.74 times more likely to develop have SUI than
those with acceptable weight.57 Interestingly, this study also found the absence of selfreported BMI a significant risk factor for the onset of SUI.57
A link between obesity and SUI symptom severity has also been reported. After
adjusting for age, ethnicity, parity, hormone replacement, smoking, and medical history,
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women who were obese were nearly twice as likely to have moderate SUI (adjusted OR
1.93; 95% CI 1.06-3.51) and over 4 times as likely to have severe SUI (OR 4.22; 95% CI
2.28-7.81) compared to women of normal body mass index.48

2.4.6 Smoking, Chronic Cough, Respiratory Disease
It is postulated that respiratory disease, chronic coughing, and smoking may cause
damage to the urethral and bladder supportive structures, causing UI. Two large
epidemiologic studies have demonstrated that older women with chronic obstructive
pulmonary disease98 and respiratory symptoms (coughing and sneezing)60 have a
significantly higher risk for UI. This association has also been described in younger
women, specifically in regard to SUI. After controlling for age, parity, menopausal
status, waist circumference, medical history, and surgeries, Zhu and colleagues reported
that history of respiratory disease was a significant risk factor for SUI (OR 1.34; 95% CI
1.03-1.75) in younger women (mean age = 45yrs).61 Additionally, a prospective cohort
study of older women (mean age of 59.5) found breathlessness significantly associated
with prevalent SUI (OR 1.4; 95% CI 1.1-1.9).50

2.4.7 Pelvic Surgery
The prevalence of women with pelvic surgery is significantly higher in women
with UI compared to continent women.60 An association between pelvic surgery and SUI
is not surprising based on the premise that surgical insult to the pelvis may decrease
pelvic organ support. Pelvic surgery may include procedures such as hysterectomy,
radical pelvic surgery, vaginal surgery, perineal trauma surgery, or radiation.62
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Hysterectomy may or may not be associated specifically with SUI. Minassian reported
that a history of hysterectomy was independent risk factor for severe SUI (OR 1.90, CI
1.07-3.37) in women (mean age = 50.8 years).48 However, van der Vaart and colleagues
found an association between hysterectomy and prevalence and incidence of UUI, not
SUI.63 Exposure to pelvic surgery regardless of type of surgery may increase risk for
developing SUI. After controlling for age, parity, menopausal status, waist
circumference, medical history, and gynecological events, women with pelvic surgery
were at significantly higher risk for SUI (OR 1.28; 95% CI 1.14-1.43) compared to those
without pelvic surgery.61

2.4.8 Chronic Constipation
Constipation has been linked as a possible etiological cause of SUI. In those with
chronic constipation, prolonged defecatory straining has been shown to contribute to
progressive neuropathy and dysfunction.46 Diokno and colleagues reported that older
women, aged 60-80+, with UI were significantly more likely to have constipation than
women without UI.60 Specifically, it appears that constipation may be more of a risk for
SUI. In a cohort study of 2390 parous women, those with post-partum constipation were
more likely to have SUI 1 year after childbirth.53 Moreover, in a large cross-sectional
survey of 20,000 Chinese women, women with chronic constipation were at significantly
higher risk for SUI (OR 1.17; 95% CI 1.02-1.34) after controlling for age, parity,
menopausal status, waist circumference, medical history, and surgeries.61
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2.4.9 Carbonated Drinks
In a study of 7046 women, (median age = 58), those who drank carbonated drinks
daily or more were significantly more likely to have SUI than those who drank them less
than once per week. Women drinking carbonated drinks daily or more had a 2-fold
increased risk for prevalent SUI (OR 2.10; 95% CI 1.57-2.81); and a 60% increased risk
(OR 1.62; 95% CI 1.18-2.22) for developing SUI at the 1-year follow-up.57

2.5 Pathophysiology of OAB and UUI
OAB is considered a symptom syndrome characterized as urgency with or
without urge incontinence, as well as frequency and nocturia.27 Urodynamically, OAB is
defined as involuntary detrusor contractions during the filling phase.9 There are two
main pathological etiologies of OAB: neurogenic and non-neurogenic causes.
Neurogenic OAB is associated with the effects on neurologic control by a variety of
conditions including spinal cord injury, stroke, Parkinson’s disease, Alzheimer disease,
diabetes, spinal stenosis, and multiple sclerosis or similar demyelinating disease.27 Nonneurogenic causes of OAB include infection, interstitial cystitis, urolithiasis, bladder and
urethral changes associated with age, bladder outlet obstruction, and pelvic floor
disorders.9
The bladder itself undergoes structural changes with age that may contribute to
overactivity.9 Elbadawi, Yalla, and Resnick examined detrusor biopsy specimens by
electron microscopy from women and men ages 65-96 years. They found structural
changes associated with age, including excessive deposits of elastic fibers between
widely separated muscle cells which may contribute to increased bladder distensibility
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and chronic retention.28 Additionally, older women have decreased urethral closure
pressure and urogenital atrophy. DuBeau proposed that the decrease in number and
density of urethral striated muscle fibers with age may contribute to OAB.99
Bladder outlet obstruction in women is due to advanced prolapse or increased
outflow resistance following continence surgery. Ultimately, the outlet obstruction
affects neurological activity by increasing the sensitivity of the detrusor muscle to
acetylcholine, which binds to detrusor muscle cells to facilitate detrusor contraction.
Subsequently, the detrusor is in a highly-excitable state resulting in involuntary detrusor
contractions.9 Finally, there is an inverse relationship between activation of the pelvic
floor muscles and the detrusor. Afferent activity from the pelvic floor muscles and the
urethra causes quieting of the detrusor during bladder filling. If afferent activity is
decreased due to pelvic floor muscle laxity, detrusor contractions may result.9

2.6 Risk Factors for OAB
2.6.1 Age
Epidemiological studies have reported an association between age and OAB.
After adjusting for ethnicity, body mass index, medical history, parity, and smoking, age
has been shown to be a significant independent risk factor for women with UUI.48 In a
large cohort study of 12,570 women, those with OAB were more likely to be older (OR
1.1; 95% CI 1.0, 1.2); 50 and for every 10-year increase in a woman’s age, the risk for
developing OAB increased by 1.2 (OR 1.2; 95% CI 1.1, 1.3).50 A different study
reported that for every 5-year increase in age, a postmenopausal woman has a 1.2
increased risk for onset UUI (OR 1.2, 95% CI 1.1-1.3).59 Moreover, the severity of UUI
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appears to increase with age. Hannestad reported that among women with severe UUI,
8% were 25-44 years of age,18% were 45-59 years of age, and 45% 60+years of age.47

2.6.2 Hysterectomy
According to a systematic review by Brown and colleagues, the odds of
developing any UI after hysterectomy is about 40% higher compared to women who have
not undergone hysterectomy.100 The literature is unclear as to whether there is a direct
connection between hysterectomy and SUI, as SUI appears to be linked to pelvic
surgeries and not specifically hysterectomy. (See section 2.4.7). However, an
association exists between hysterectomy and UUI. In a cross-sectional study of 2,322
women aged 35-70, women with a hysterectomy reported a significantly higher rate of
any UUI as well as bothersome UUI (P<0.0001) compared to those not having a
hysterectomy. After adjusting for age, parity, and educational level, women with a
hysterectomy had nearly a 2-fold higher risk for any UUI (OR 1.93; 95%CI 1.40-2.63)
and over a 2.5-fold risk for bothersome UUI (OR 2.63; 95%CI 1.39-4.41) compared to
those without a hysterectomy.63

2.6.3 Neurological conditions
Women with neurological conditions also have an increased risk for UI as certain
neurological disorders interfere with the normal tonic inhibitory pathways controlling
micturition.9 Specific neurological conditions that may interfere with these pathways
include stroke, Parkinson’s, brain tumors, traumatic brain injury, Alzheimer’s dementia,
cerebral palsy, and multiple sclerosis.9 Diokno and colleagues demonstrated that the
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percentage of women, aged 60 to 80+, with diseases of nerves and/or muscles was
significantly higher in women with UI compared to continent women.60
Specifically, bladder dysfunction is a very common problem in those with
multiple sclerosis (MS), with as high as 84% of persons with MS reporting bladder
symptoms.101 The most common underlying bladder abnormality in persons with MS is
neurogenic detrusor overactivity, affecting 37-99% of those with bladder dysfunction.102
Neurogenic detrusor overactivity refers to a voiding dysfunction due to neurologic
damage from trauma or disease. Irritative symptoms associated with neurogenic detrusor
overactivity include urgency to urinate, frequent urination, nocturia, and urge
incontinence. Patients with MS may also demonstrate detrusor-sphincter dyssynergia in
which there is incomplete bladder emptying because the external urethral sphincter does
not relax during detrusor contraction. Patients with detrusor-sphincter dyssynergia
experience obstructive voiding symptoms of urinary hesitancy and interrupted urinary
flow as well as urinary retention.103, 104 Obstructive symptoms affect between 34-79% of
patients with MS.102 Additionally, approximately 51% of women with MS experience
both detrusor overactivity and detrusor-sphincter dyssynergia demonstrating symptoms
both of failure to store and failure to empty.102

2.6.4 Caffeine & Carbonated Drinks
Arya, Myers, and Jackson reported an association between high caffeine intake
and OAB.56 Women with urodynamically confirmed OAB consumed significantly more
caffeine (484 mg/day) than women without OAB (194 mg/day, p=0.002). After
controlling for age and smoking, women with high caffeine intake (> 400 mg/day) were
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2.4 times (OR 2.4, 95% CI 1.1-6.5) more likely to have OAB than women with minimal
caffeine intake (<100 mg/day).56 To put the amount of caffeine in perspective, a 5 ounce
cup of brewed coffee with caffeine has 128 mg, a 8-oz glass of iced tea has 47 mg of
caffeine, and a 8-oz glass of cola soft drink has 25 mg.56
Women consuming just 2-6 carbonated beverages per week are at increased risk
for OAB. When examining the impact of carbonated beverages alone, Dallosso and
colleagues found that women who consumed 2-6 carbonated beverages per week had
nearly a 50% increased risk for onset OAB (OR 1.44; 95% CI 1.12-1.85) compared to
those consuming less than one beverage per week. Risk increased to 70% for women
consuming at least one carbonated beverage daily. When considering carbonated
beverages along with other potential risk factors, women consuming at least one
carbonated beverage daily increased their risk for onset OAB 1.4 times (OR 1.41; 95% CI
1.02-1.95) compared to those drinking less than one such beverage per week.57

2.6.5 Lifestyle Habits: Smoking and Obesity
Women who smoke are also at higher risk for OAB. Data suggests that women
with urodynamically diagnosed OAB were significantly more likely to be current
smokers compared to those without OAB (p<0.04). Those who were current smokers
were nearly twice (OR 1.9; CI 1.0-3.8) as likely to demonstrate OAB compared to those
that never smoked.56 Similarly, Dallosso and colleagues reported that current smokers
were 1.44 times more likely to develop OAB than nonsmokers (OR 1.44, 95% CI 1.051.98).57
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Obesity is significantly associated with an increased risk of OAB. Women that are
obese have a significantly increased risk of onset OAB (OR 1.46, 95% CI 1.02-2.09)
compared to those who are of acceptable weight.57 Waetjen and colleagues reported that
an increased body mass index was a significant risk factor for prevalent and incident
UUI. For every unit increase in BMI, the prevalent and incident risk was 1.03 (adjusted
OR 1.03; 95% CI 1.00-1.60).54

2.6.6 Functional Status: Decreased mobility, decreased ADLS, & Arthritis
Mobility issues vary significantly between incontinent and continent elderly
women.60 Goode and colleagues investigated risk factors for UI over a 3 year period in
older women (mean age = 75 years).105 Participants completed an in-home interview and
in-home physical tests. Women with a slower time for 5 chair stands were at a
significantly higher risk (OR 1.3; 95% CI 1.0-1.6) for developing UI.105 The status of
mobility may possibly impact women with UUI more than SUI. In another study, older
women (aged 60 to 80+) with UUI reported more assistive device use (wheelchair, cane,
crutches, or walker) compared to those with SUI or mixed UI. 60
Logically, co-morbidities affecting mobility may also have in impact on
continence status. Diokno and colleagues demonstrated that the percentage of women,
aged 60 to 80+, with a medical diagnosis of arthritis was significantly higher in women
with UI compared to continent women.60 With respect to type of UI, arthritis may have
more of an association on UUI than SUI. In a study of women with a median age of 50.8
years, those who reported having arthritis were 2.32 times (adjusted OR 2.32; 95% CI
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1.17-4.63) more likely to report severe UUI compared to women without incontinence.
Such an increased risk was not apparent for SUI.48

2.7 Non-specific risk factors for UI
2.7.1 Pelvic Organ Prolapse
Pelvic organ prolapse (POP) is defined as the descent of the apex of the vagina or cervix
(or vaginal vault after hysterectomy), anterior vaginal wall, or posterior vaginal wall; and
can occur in association with UI.1 As the prolapse advances, organs can protrude outside
the vaginal canal. Women with POP may describe a feeling of a lump, low backache,
heaviness, dragging sensation, or the need to digitally replace the prolapse to void or
defecate.1 The inter-relation between POP and pelvic floor symptoms can be generally
explained by the following scenarios:106
1. POP is the direct cause of the symptom (i.e. vaginal bulging, pelvic pressure).
2. Loss of vaginal support contributes dysfunction of nearby organs (i.e. SUI in
women with anterior vaginal prolapse).
3. A common pathogenic mechanism is shared by POP and the condition causing the
symptoms (i.e. muscular injury and pelvic floor denervation after vaginal delivery
as a cause of prolapse and fecal incontinence).
4. The symptom is a contributor to the development of POP (i.e. chronic straining to
defecate).
5. There is no causal relationship between vaginal prolapse and the condition
causing the symptoms, but both conditions are common and are seen together in a
subset of women (i.e. chronic low back pain).
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Normal pelvic organ support depends upon the integrity of the LA, supportive
connective tissue (endopelvic fascia), and normal innervations.91 If the LA functions
normally, the urogenital hiatus narrows and the connective tissue is under minimal
tension, able to stabilize the organs in their position above the LA. If the LA relaxes or
is damaged, the urogenital hiatus opens and the vagina must be held in place by the
fascia. Although the fascia can sustain the load for short periods of time, the connective
tissue eventually fails, resulting in prolaspe.91 Loss of connective tissue support107 and/or
LA function91 have been proposed as mechanisms for POP.
Urinary symptoms are common among women with POP. The anterior vaginal
wall supports the bladder and urethra and loss of this support may lead to urethral
hypermobility which may contribute to SUI.106 Mechanical obstruction of the urethra
may contribute to UUI; and the obstruction may be due to either anterior or posterior
vaginal prolapse. Anterior vaginal prolapse may cause the urethra to kink, while posterior
vaginal prolapse may cause direct urethral compression rather than kinking.106 Over
time, the obstruction may result in structural changes of the bladder or urethra leading to
OAB.9 Typically, when the prolapse is mild, SUI coexists. Conversely, when the
prolapse extends beyond the hymen, women are less likely to report SUI but more likely
to report UUI as the prolapse is obstructing the urethra. In a study of 237 women with
symptomatic POP, a significant inverse correlation was observed between the severity of
prolapse and SUI. Additionally, as prolapse worsened, direct correlations were noted with
symptoms indicative of UUI including hesitancy, intermittent flow, and difficulty
voiding.30
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2.7.2 Medications
Older women are more likely to take medications that may cause UI.
Approximately 60% of older men and women take at least one prescribed medication.
About one third of older adults take more than five prescribed medications, and many
also take over-the-counter and naturopathic/herbal drugs.99 Medication that affects
cognition, mobility, fluid balance, coughing, detrusor contractility, or sphincter function
can impair continence. Several medications are associated with UI in women including:
diuretics, estrogen, benzodiazepine, tranquilizers, antidepressants, hypnotics, laxatives,
and antibiotics.108 Medications may impair detrusor contractility (anticholinergics,
narcotics, calcium channel blockers, nonsteroidal anti-inflammatory agents), cause
urinary retention (anticholinergics, narcotics, calcium channel blockers), or promote
nocturia from pedal edema (calcium channel blockers, gabapentin and pregabalin,
thiazolidinediones, nonsteroidal anti-inflammatory agents).99
Medications that may promote SUI symptoms include ACE inhibitors and αblockers. ACE inhibitors may cause excessive coughing, while α-blockers can cause
sphincter relaxation. Medications that may lead to UUI symptoms include: β-blockers,
which irritate the bladder; cholinergics and diuretics which promote high urine flow; and
sedatives-hypnotics, antipsychotics, narcotics, and alcohol, which depress the central
nervous systsm.62

2.7.3 Fluid Intake
The amount, timing, and type of beverages consumed my increase a woman’s risk
for UI. Some women believe that drinking excessive amounts of water will promote
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health and weight loss. Unfortunately, this behavior may lead to polyuria and
exacerbation of urinary frequency and urgency. Other women may limit fluid intake to
decrease their bladder symptoms.62 Yet, dehydration leads to concentrated urine within
the bladder and low urine production. Low urine volume will limit bladder expansion,
and over a period of time can lead to reduced bladder capacity, decreased detrusor tone,
and increased bladder wall thickness.109 These structural changes may contribute to
further continence problems. Additionally, low fluid intake may contribute to urinary
tract infection and fecal impaction which may irritate the detrusor causing urgency and
frequency. Concentrated urine can aggravate the bladder mucosa and trigone and lead to
urgency and frequency. It is recommended that patients avoid extreme fluid intake.
Instead it is recommend that adults consume 30mL per kg of body weight (or 0.5 oz per
lb of body weight).62
The timing of fluid intake is crucial for women with nocturia. Nocturia is the
complaint of waking at night one or more times to void.1 It affects up to 90% of older
women by age 80.99 Older women have delayed fluid excretion, and tend to void later in
the day, evening, and night.110 50% or more of their 24-hour urine output may occur
during the night.99 Subsequently, women consuming most of their fluids later in the day
may be more prone to UI episodes in the evening or night. Regarding type of fluid,
carbonated drinks increase the risk of SUI57 and OAB,57 while caffeine increases the risk
for OAB.56
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2.7.4 Fecal Incontinence
Women with fecal incontinence (FI) are at a higher risk for UI. When controlled
for age, parity, antidepressant use, and previous hysterectomy, FI has been shown to be
independently associated with UI (OR 6.3; 95% CI 2.6-19.1) in women with POP or UI.33
Markland and colleagues demonstrated that in overweight and obese women (mean age =
53 years), FI was independently associated with increased urinary tract symptoms.32
Conversely, women having more frequent UUI symptoms have increased risk (OR 1.2;
95% CI 1.0-1.3) of FI.64 Women with both FI and UUI scored significantly lower on the
Urinary Distress Inventory compared to women who have isolated UUI64 indicating
greater symptom impact. This finding gives strength to the presumption that dual
incontinence may have more impact on urinary distress than having UI alone.

2.7.5 Pelvic Pain
According to the American College of Obstetricians and Gynecologists, chronic
pelvic pain (CPP) is a descriptive diagnosis that refers to pain of 6 months or more that is
localized to the anatomic pelvis, anterior abdominal wall at or below the umbilicus, the
lumbosacral back, or the buttocks and is of sufficient severity to cause functional
disability or lead to medical care.111 After controlling for age, parity, alcohol
consumption, waist circumference, constipation, menopausal status, and medical history,
chronic pelvic pain was found a significant risk factor (OR 1.53; 95% CI 1.36-1.72) for
SUI in a large cross-sectional survey of 20,000 Chinese women.61 In a smaller crosssectional survey (319 Iranian women, mean age = 33.8), women with pelvic pain reported
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statistically significant higher rates of SUI and OAB symptoms (urgency, frequency) than
women without pelvic pain.66

2.8 Co-existing pelvic symptoms
2.8.1 Dual Incontinence and Pelvic Organ Prolapse (POP)
A varying proportion of women will experience UI, FI, and/or POP. Jackson and
colleagues found that among 247 women with either UI or POP, coexisting FI occurred
in 31% and 7% of those UI and with POP, respectively.31 Ellerkmann and co-workers
reported that 86% of women with POP had urinary urgency and frequency, while 31%
reported co-existing FI.30 Finally, Markland reported that presence of dual incontinence
(UI and FI) was 18% in women (mean age = 57) participating in a treatment study for
UUI.64
The rationale for why pelvic symptoms co-exist is complex. These conditions are
associated with damage to the pelvic floor either through mechanical disruption of
connective tissue, or through direct and secondary muscle or nerve injury. Because the
conditions share common etiologies, they also share many common risk factors.46
Vaginal delivery, POP, higher body mass index, and UUI symptoms have been reported
as significant risk factors for dual incontinence (DI).64 Ng and colleagues reported
similar findings, identifying vaginal delivery, POP, and urinary symptoms to be
predictors of FI in women (mean age 45) with SUI, OAB, or mixed incontinence.
Difficulties in ADLS, depressive symptoms, chronic diarrhea, and higher co morbidity
scores have been correlated with DI older women.112
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2.8.2 Constipation
Prevalence rates of constipation in women with urinary symptoms are much
higher than in the general population, with typical U.S prevalence rates ranging from 1519%.113, 114 In a study of 302 women (mean age = 60 yrs) with either POP or UI, 36%
had constipation as defined by the Rome II criteria, a symptom-based questionnaire
developed by clinical consensus.33 Similarly, Ng and colleagues reported 31.5% of
women with SUI or OAB (mean age= 45 yrs) experienced co-existing constipation
defined as ≤3 bowel movements per week.34 The literature linking constipation as a coexisting symptom is based on the premise that straining during defecation may lead to
pudendal nerve damage and subsequent denervation of the pelvic floor. Such etiologies
have also been implicated in UI, FI, and POP.46

2.8.3 Sexual Dysfunction
Women with UI or lower urinary tract symptoms (LUTS) have a higher rate of
sexual dysfunction compared to the general, healthy female population without urinary
symptoms.115 Women aged 19-66 years with UI or LUTS have been found to score lower
on the Female Sexual Function Index when compared to healthy controls. Specifically,
women with UI or LUTS had lower scores for items assessing sexual desire, lubrication,
and sexual satisfaction as well as significantly higher scores for sexual pain.115
Moreover, in a large national survey of 1749 women aged 18-59 years, those with
urinary tract symptoms had a 4-fold higher risk for sexual arousal dysfunction (OR 4.20;
95% CI 2.75-5.89) and a 7-fold risk for sexual pain with intercourse (OR 7.61; 95% CI
4.06-14.26) after adjusting for health and lifestyle factors, social status, and sexual
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experience.35 Pain with sexual intercourse, termed dyspareunia, can be classified as a
subset of chronic pelvic pain provided that the patient has symptoms for ≥6 months.

2.8.4 Chronic Pelvic Pain
In women, several causes of chronic pelvic pain (CPP) are recognized, and many
disorders of the reproductive tract, urological organs, and gastrointestinal,
musculoskeletal, and psychological systems may be associated with CPP. The most
frequent causes of CPP include interstitial cystitis,116-118 irritable bowel syndrome,116, 117
post-operative adhesions,117 pelvic varices,117 vulvodynia116, 118 and musculoskeletal
issues.118 There is controversy whether to include endometriosis as a cause of CPP as
most consider endometriosis to be its own entity.117 Endometriosis is the presence of
extrauterine endometrial tissue and usually presents with symptoms concurrent with the
menstrual cycle.116 This condition affects other organ systems causing bowel motility
issues, bladder dysfunction, and pain. Unlike other causes of CPP, endometriosis can be
treated effectively with drugs, surgery, or both.117

2.8.4.1 Sources of CPP
Interstitial cystitis: According to the National Institute of Diabetes, Digestive and Kidney
diseases, interstitial cystitis is pain, pressure, or discomfort of the bladder and the
surrounding pelvic region. Symptoms include urinary urgency and/or urinary frequency
in addition to pressure, discomfort, or tenderness in the bladder area.119 The National
Institute of Diabetes, Digestive and Kidney diseases research-related definition of
interstitial cystitis has inclusion and exclusion criteria based on cystoscopic, urodynamic,
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and other laboratory tests.116 Because of this strict definition, there is acknowledgement
of a more generic painful bladder syndrome which simply refers to painful urinary
symptoms. In interstitial cystitis/painful bladder syndrome, the bladder wall may become
irritated causing scarring and glomerulations. People with severe cases of interstitial
cystitis/painful bladder syndrome may urinate up to 60 times a day and complain of
nocturia.119 In addition, about 10-15% of patients with interstitial cystitis/painful bladder
syndrome have OAB.117
Irritable bowel syndrome: Irritable bowel syndrome is a disorder in which abdominal
discomfort or pain is associated with defecation or altered bowel habits. Approximately
35% of women with CPP have irritable bowel syndrome.120 The diagnosis is based upon
the Rome II criteria. The patient must experience over the past 12 weeks abdominal
discomfort or pain that has at least two out of the three following features: relieved with
defecation, onset associated with a change in frequency of stool, and/or onset associated
with a change in form (appearance) of stool.121 The suggested etiology of irritable bowel
syndrome includes altered bowel motility, visceral hypersensitivity, and psychological
factors. Pain may be produced from the visceral hypersensitivity of the intestinal wall
and/or degranulation of activated mast cells117 whose contents aggravates nociceptors via
the inflammatory response. Additionally, the overdistention of the colon wall by bowel
content and gas may stimulate stretch receptors.117
Post-operative adhesions: Adhesions in the pelvis may be caused by acute or chronic
inflammatory disorders (i.e. tubo-ovarian infections and enometriosis) or a physicochemical trauma such as surgery. The role of adhesions in CPP is controversial and
although adhesions are found in 25-50% of women with CPP, it is unclear whether the
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association is causal. It has been postulated that intraperitoneal adhesions may cause pain
with activities such as running or sexual intercourse due to the stretching of the
peritoneum or visceral serosa at the adhesion’s attachment site. When the peritoneum is
compressed or stretched, nociceptors in the adhesion become activated potentially
signaling pain. However, although adhesions contain nerve fibers, the presence of nerve
fibers alone is not evidence of a causative role as pain perception requires a complex
linking network.117
Pelvic varices:117 Pelvic congestion syndrome is a myriad of pain symptoms associated
with presence of ovarian and pelvic (internal iliac) varices and result in decreased
function of the venous system. The pain related to pelvic congestion syndrome is
possibly due to pelvic congestion, leading to dilation and stasis that aggravate the local
inflammatory response. The etiology of pelvic congestion syndrome is unknown but it is
hypothesized that psychological, sexual, and genetic-biological factors may be related.
Approximately 30% of patients with CPP have pelvic varices as the source of their CPP,
and an additional 12% have pelvic varices in addition to other pelvic pathologies.117
Patients with pelvic varices as the source of their CPP complain of a changing location of
pain, congestive dysmenorrhea, deep dysparenia and post-coital pain, and a dull chronic
pain exacerbated after activities of pelvic engorgement including prolonged standing and
working for many hours in a sitting position.117
Vulvodynia: The International Society for the Study of Vulvar Disease defines
vulvodynia as “chronic rawness, irritation, burning and soreness in the absence of
abnormal finding except redness at times.”122 Two broad categories exist for further
defining this condition: secondary and primary vulvodynia. Secondary vulvodynia is
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pain that is due to an observable vulvar or vaginal lesion and include dermatological
conditions which cause inflammation, ulceration, blisters, fissures and adhesions, and
conditions that cause vaginitis. Primary vulvodynia is pain that is experienced in the
absence of any observable vulvar pathology and may include neuropathic pain, referred
pain, and introital dyspareunia in patients with a normal vulva.123 Women with
vulvodynia may experience allodynia or hyperalgesia in conjunction with the symptoms
of rawness, irritation, and burning. In women with neuropathic pain, it is postulated that
injury to sensory nerves to the vulva (ilioinguinal and genitofemoral from L1-2) or to the
pudendal nerve is the source of the condition. In women with referred pain to the vulva,
it is postulated that the low back or bladder may be the primary source of the dysfunction.
Additionally, women with vulvodynia may complain of frequency, urgency, and burning
on urination due to alterations of sensation to nearby viscera.123
Musculoskeletal issues
Trigger points: CPP can be due to the presence of active myofascial triggers points in the
external and internal muscles of the pelvic region. Trigger points are focal points of
tenderness found at multiple sites in a muscle and the fascia of muscle tissue.124 Trigger
points typically have a clear and consistent referred pain pattern; arise in response to
acute or chronic overload; cause increased muscle tension, weakness, and limited range
of motion; and disrupt the proprioceptive, nociceptive, and autonomic functions of the
affected areas.124 Trigger points in the anterior pelvis may refer pain to the vagina and
can cause entry dyspareunia and pain in the perineal region. Trigger points in the deeper
pelvic muscles (LA, obturator internus) can affect bladder and bowel function.124 By
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manually releasing trigger points in the pelvic floor muscles in patients with severe
urinary urgency and frequency, Weiss reported an 83% reduction in symptoms.125
Pelvic floor muscle dysfunction: Pelvic floor muscle dysfunction refers to hypotonicity
or hypertonicity of the pelvic floor muscles (LA and coccygeus). Hypotonus dyfunction
may be due to hormonal factors, mechanical damage, weakness and are generally
associated with UI, FI, and POP.46 Bernstein demonstrated that women with urinary
symptoms and subpubic pain had significantly less pelvic floor muscle activity when
asked to contract their pelvic floor muscles compared to controls.126 This suggests that
hypotonus of the pelvic floor muscles may play a role in pelvic pain. More commonly,
hypertonus or spasm of the pelvic floor muscles may contribute to CPP and has been
implicated in interstitial cystitis,125, 127 dyspareunia,128 severe urgency and frequency
with/without urethral pain,125 and vulvodynia.123 Women with interstitial cystitis and
hypertonicity of the pelvic floor muscles who underwent physical therapy consisting of
intravaginal massages using the Thiele technique reported significantly decreased
symptoms, improved quality of life, and significantly decreased pelvic floor muscle
hypertonicity when compared to pre-treatment scores.127 Similarly, 10 women with
interstitial cystitis who received Thiele massage to hypertonic pelvic floor muscles
demonstrated post-treatment decreased pelvic floor muscle tone as measured by surface
electromyography.125 Although it is acknowledged that intravaginal palpation and
surface electromyography are not the gold standard for measuring muscle tone, such
investigations shed light that pelvic floor tone may play a crucial role in the
pathophysiology of CPP. The relationship between hypertonicity and pain is not
completely understood. In response to pain, a muscle may contract or guard to protect
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against further injury thus contributing to the pain-spasm-pain cycle. Persistent muscle
overactivity can lead to excessive activity of gamma efferent neurons (gamma gain)
which may cause muscle spindles to become hyperactive and lead to adaptive shortening
of surrounding fascial tissue.129 Thus, pelvic floor muscle dysfunction may be primary or
secondary generators of nociceptive signals. Although their role is not clearly defined as
causal, it is evident the PFM dysfunction should be considered when treating patients
with CPP.
Low back pain: Low back pain (LBP) can be considered part of CPP if, according to the
CPP definition, it is greater than 6 months in duration and of sufficient severity to cause
functional disability or lead to medical care. Additionally, low back pathology can refer
pain to the pelvic floor and should be considered in differential diagnosis of CPP.130
Eliasson reported an association of LBP and UI.67 In a cross-sectional study of 200 nonpregnant women seeking physical therapy for LBP, those with LBP reported significantly
more UI (p<0.001) and more severe UI (p<0.001) than a reference group of women
without LBP of comparable age and parity. Additionally, women with LBP were 3 times
more likely to have UI compared to the reference group (nulliparous OR 3.1; 95% CI 1.85.6; parous OR 2.7; 95% CI 1.6-4.5). Interestingly, women with LBP were significantly
less able to interrupt the urine flow than the reference group; and the inability to interrupt
urine flow was a significant risk factor for UI (nulliparous OR 1.8; 95% CI 1.3-2.5;
parous OR 3.8; 95% CI 2.7-5.7).67
Hip Pain: Gender differences exist in the anatomy of the hip and pelvis. Specifically, the
female pelvis is broader than men, and those women who have even broader pelvises
may have greater hip range of motion.130 In addition, women are more likely to have
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developmental dysplasia of the hip which also may contribute to hypermobility.131 Based
on orthopedic treatment principles, if hypermobility exists, there is a need to increase
strength of the surrounding muscles (in this case the pelvis) to reduce the hypermobility.
Additionally, there may be a component of hypomobilty in surrounding structures (i.e.
pelvic floor muscles) that may need to be addressed. Moreover, hip pathology may refer
pain to the pelvic floor muscles130 and when determining the source of CPP, the hip joint
should be considered as possible etiology.
Postural and Movement Considerations: Poor posture, such as exaggerated lumbar
lordosis or thoracic kyphosis, or poor body mechanics may cause excessive loading on
the spine, hip or pelvic floor muscles leading to CPP.117, 128, 132 Faulty posture may cause
muscle weakness and deconditioning, and lead to muscle imbalances and development of
trigger points and hypertonicity.117 Hodges and colleagues observed a connection
between the pelvic floor muscles to both postural and respiratory functions.133 Using
surface EMG, Hodges reported that pelvic floor muscle (PFM) activity increased in
anticipation of arm movements designed to challenge postural stability. Furthermore,
PFMs remain active during sustained postural tasks (in this case, repetitive arm
movements). During quiet breathing in the standing position, PFM activity was
significantly increased during expiration verses inspiration. Compared to quiet breathing,
PFM activity increased during larger breaths, increased tidal volumes, and expiration.133
Hodges’ work is the first to provide evidence that the PFMs play a role in both postural
and respiratory functions; and to give insight into the coordination of posture, continence,
and respiration. Based on this evidence, it is possible that changes in postural stability or

46

respiratory patterns may contribute to increased demands on the PFM. However, more
research is necessary to support this assumption.

2.9 Interventions for SUI
2.9.1 PFM exercise
One of the most frequent treatments for SUI is PFM exercises or contraction of
the LA. The premise of this intervention is that a strong LA contraction will improve
urethral closure and pelvic organ support. It is hypothesized that compression of the
urethra by contraction of the PFM will stop urine leakage if the contraction is of
sufficient force and properly timed. Miller and colleagues reported a significant increase
in mean urethral closure pressure during a PFM contraction in continent women (mean
age = 55.7) measured urodynamically.20 In addition, mean urethral closure pressure was
significantly lower in women with SUI than continent women. Moreover, urethral closure
pressure had the largest effect size in differentiating between continent and incontinent
women.19 Thus, if women with SUI have a reduced urethral closure pressure,
interventions aimed at increasing this pressure (i.e. PFM contraction) may lessen urinary
leakage. Additionally, contraction of the PFM may prevent urethral descent with abrupt
rises in intra-abdominal pressures that occur with activities such as coughing, sneezing,
and lifting. DeLancey and colleagues reported that women with SUI had greater urethral
descent at maximal valsalva compared to continent women, however the trend did not
reach statistical significance.19 Miller compared bladder neck mobility of 11 young,
continent, nulliparous women to 11 older, incontinent parous women during coughs with
and without a concomitant PFM contraction. Bladder neck mobility significantly
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decreased from a median 5.4 to 2.9 mm when the PFM contraction was performed.22
Thus, PFM contraction appears to minimize urethral descent, but whether or not it leads
to reduced SUI symptoms has not been scientifically verified. However, hypertrophy of
the PFM as a result of exercise may improve urethral closure pressure and structural
support of the pelvic organs.
The levator ani (PFMs) muscles consist of type I and type II muscle fibers. The
type I fibers contribute to the static function of the muscle which is to support the pelvic
viscera. The type II fibers are associated with rapid, forceful muscle contraction. When
LA biopsy specimens of women with SUI were analyzed by Koelbl et al, women with a
greater diameter of type II fibers had significantly higher urethral closure pressures
during coughing.134 This finding suggests that LA type II fiber size is associated with
urethral sphincter performance. Because specific strength training exercises can affect
type II muscle fiber size through hypertrophy, it seems likely that LA exercise could
increase the compression function of the muscle. In this way, strengthening type II fibers
of the LA could aid the urethral sphincter in maintaining continence. Additionally,
intensive LA strengthening may increase connective tissue stiffness and muscle
hypertrophy. These morphological and functional changes may improve structural
support of the pelvis by elevating the LA to a permanently higher location.
Subsequently, the increased support may assist in preventing downward descent during
increases in abdominal pressure.21
Practitioners treating persons with SUI frequently utilize PFM exercise, also
known as Kegel exercises. PFM exercises are taught either by verbal instruction or
manual palpation, and specifically elicit contraction of the LA. While PFM exercises are
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a reasonable way to address SUI, this treatment is not uniformly effective. The severity
of the incontinence being treated and characteristics of the exercise program itself
influence the effectiveness of treatment.
It appears that PFM exercises are most effective when used to treat persons with
mild incontinence. When women suffering from mild or severe SUI were treated with
PFM exercises for three months, those with mild SUI reported symptom improvement
86% of the time, those with severe SUI only reported improvement 13% of the time.15
Moreover, those with mild SUI who improved with exercise also had significantly
improved urethral closure pressures.15 Cammu et al studied outcomes of women with
SUI following at least one session of PFM exercise training with a physical therapist.14
Approximately 50% of the women were treated successfully. Women with more severe
incontinence, defined as > 2 episodes of leakage per day and having a leakage at first
cough during a stress test, were more likely to have poor outcomes associated with PFM
training. Similarly, Burgio reported that women with severe SUI (defined as having
more than 10 incontinent episodes per week on bladder diary) were less likely to have a
successful outcome with PFM exercise compared to those with lesser severity.13
PFM exercise efficacy studies including women with mild to moderate SUI vary
with respect to frequency and intensity exercise. For example, Goode and colleagues
tested a protocol in a sample of women with mild to moderate stress and mixed UI that
required women to perform 15 repetitions of 2-4 second contractions, three times per day
for 8 weeks.16 These investigators reported at least 50% of women reported a 67%
decrease in voiding frequency and an 80% reduction of incontinence. Eighteen percent
of the women reported cure or 100% reduced symptoms. It must be noted that in
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addition to PFM exercises, subjects were instructed in the “Knack” principle. The Knack
or counterbracing technique is taught by clinicians to prevent leakage during increases in
abdominal pressure. The patient is taught to contract the PFM just prior to the physical
stress. For instance, if a woman is about to sneeze, she should contract her PFM just
prior to and throughout the sneeze to prevent SUI. In theory, the PFM contraction
increases the pressure of the urethra to assist in preventing leakage of urine.
A randomized controlled trial, performed by Miller et al, evaluated the
effectiveness of the Knack alone to reduce SUI. In this study, women were taught to
contract their PFMs before and during a cough. A paper towel test served as the study
outcome measure and was compared between baseline and 1 week later. Using the
Knack decreased urinary leakage by 98.2 % for a medium cough and 73.3% for a deep
cough.73
Because Goode, et al incorporated the Knack, it is unclear what contribution each
intervention (PFM exercises or behavioral training utilizing the Knack) made to reducing
UI in the women observed. Other limitations of Goode, et al’s study include a short time
period for muscle training. The maximal effect of strength training does not occur before
5 months of training.21 Thus, the duration of Goode’s study may have been insufficient to
promote PFM hypertrophy. Additionally, this study did not include PFM muscle testing
to support or discredit whether 8-weeks of PFM exercise increased PFM strength.
Studies that trained women longer and tested the impact of PFM exercise alone to
reduce SUI have found favorable results. According to a Cochrane Review of PFM
training, greater improvements occur when women receive a supervised PFM exercise
program of at least three months.17 Bo et al. found that women with SUI who performed
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PFM exercises were 17 times more likely to report cure than a control group. In Bo et
al.’s study, subjective cure was defined as a condition that was “unproblematic” after
treatment. Women in this study performed 8-12 high intensity PFM contractions, three
times a day. In addition to the home exercises, they attended PFM training in groups once
a week with a physical therapist over a 6 month trial period. Women who performed
PFM exercises also demonstrated significant improvements in PFM strength, episodes of
leakage, and quality of life.11
Morkved, et al reported a 29% subjective cure rate for women with SUI using a
similar protocol of 10, high intensity PFM contractions three times a day, and additional
training with a physical therapist (weekly for 2 months, then bi-weekly for 4 months), 18
Women in the study also demonstrated significant improvements in gram leakage on a
pad test and quality of life after treatment. Interestingly, the investigators utilized 3 time
points to measure PFM strength: 0-3 months, 3-6 months, and 0-6 months. They found
significant improvements in strength from baseline to 3 months and from baseline to 6
months. This suggests that perhaps hypertrophy gains in the PFM could be obtained in as
little as 3 months or that the 3 month intervention increased neural activation of the PFM
resulting in improved manual muscle testing scores.
Other investigators have demonstrated improvements in subjective cure rates and
objective measures in women with SUI participating in a supervised program of PFM
exercises for 3 months. Borello-France and colleagues found 41% of women with SUI
performing PFM contractions for 9-12 weeks experienced a 100% resolution of SUI
symptoms while another 20.5% experienced at least a 75% reduction in symptoms.
Additionally, the women demonstrated significant improvements in the number of urine
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leaks per week, PFM strength, and quality of life.70 Women performed a home exercise
program ranging from 20-90 repetitions per day and attended weekly individual sessions
with a physical therapist. It should be noted that the women were also taught the “stress
strategy” which is the same strategy as the Knack, described previously. Yet, because
Borello-France, et al observed women increased PFM strength, it is possible that PFM
hypertrophy and not merely the Knack behavioral instruction contributed to reducing
SUI. Additionally, the protocol utilized by Borello-France called for a high maximum
exercise dosage. By visit 12, the maximum exercise prescription possible was 60
repetitions (3 sets of 20) of a 3-second contraction and 30 repetitions (3 sets of 10) of a
12-second contraction performed twice daily. Given the high number of exercises
prescribed, hypertrophy of the PFM could have occurred and contributed to the
effectiveness of the intervention. Another high exercise intensity protocol described by
Aukee et al resulted in decreased UI measured by a 24-hour pad test. The protocol
required women with SUI to perform PFM contractions 20 minutes per day, and attend 5
structured physical therapy sessions over a 12 week treatment period. This study also
supports that a 3 month protocol of PFM exercise may be effective in decreasing SUI.23
It appears that PFM training is an effective conservative treatment for women
with mild to moderate SUI. If the treatment protocol is over a longer period, for instance
6 months, then appropriate dosage of contractions may include 8-12 high-intensity
repetitions performed three times a day. However, if the treatment protocol is over a
shorter period, for instance 3 months, then it appears that similar results could be
obtained if a more aggressive dosage is prescribed. Borello-France and colleagues
utilized an individualized approach to exercise prescription. The physical therapist
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determined the subjects’ level of fatigue when performing the PFM exercise based on
performance on electromyography biofeedback. Based on the performance, the physical
therapist prescribed the number of repetitions for the patients to perform during the home
exercise program. Borello-France et al’s approach reflects common practice in physical
therapy settings. The physical therapist evaluates the patient and prescribes exercises
based on examination findings of the patient’s muscle performance. Additionally,
Borello-France et al incorporated both 3-second maximum and 12-second submaximal
PFM contractions to train both type II muscle fibers and type I muscle fibers respectively.
Activation of type II muscle fibers may encourage hypertrophy, while activation of type I
muscle fibers may contribute to pelvic organ support and prevent strain on pelvic
ligaments and fascia. Both Morkved et al18 and Bo et al11 exercise protocols incorporated
3-4 fast PFM contractions on top of each 6-8 second muscle contraction. This protocol
also incorporates both type I and type II muscle training. According to the Cochrane
Review, it seems likely that treatment effectiveness will be enhanced if the exercise
prescription is based on sound physiological principles.17 The studies mentioned in this
review are consistent in incorporating both PFM endurance and strengthening principles.
In summary, PFM training is better than no treatment, for women with SUI. Although
exercise variables differ, an effective PFM training program should include both
endurance and strengthening contractions, and may be more effective if the number of
repetitions is individually based upon the patient’s level of fatigue during performance.
Studies reveal that a 3-month regime is effective if sufficient repetitions are included in
the program.
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In addition to considering the intensity and duration of a PFM exercise program,
physical therapists may also need to consider the body position in which woman exercise.
Bo and Finckenhagen reported that mean resting vaginal pressure (cm HOH) was higher
when recorded with women standing than when women were supine. The positions of
standing or sitting did not affect the subjects’ ability to produce maximum squeeze
pressure or maximum PFM contraction.68 Yet, the higher resting pressure recorded in
standing suggests that vaginal pressure may be influenced by gravity. Borello-France and
colleagues compared the efficacy of a PFM exercise progression that included practice in
upright positions (supine, sitting, and standing) with the effectiveness of a PFM exercise
program performed only in the supine position in reducing SUI.70 Women in both
exercise groups achieved statistically significant improvements in urinary leakage,
quality of life, and PFM strength. Position of PFM exercise did not impact outcomes70
indicating that perhaps exercise position may not play as important of a role in reducing
UI. However, the authors did incorporate “Knack” training in both groups, which
allowed women in the supine only exercise group the opportunity to contract their
muscles in anti-gravity postures. This, combined with the high-intensity of both exercise
regimes, may have reduced the impact of exercise position on study outcomes. Clinically,
physical therapists utilize exercise progression from gravity-eliminated to anti-gravity
when strengthening the PFM. Although one study70 disputed this common practice, the
specificity theory regarding motor tasks states that greater gains in motor performance
occur when practice most closely resembles the functional task.135 Thus, until additional
studies corroborate the findings of Borello-France et al, exercise position should continue
to be considered as a variable for PFM exercise.
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2.9.2 SUI: PFM exercise and Biofeedback
Although PFM exercises are effective in reducing SUI in women with mild to
moderate symptoms, the methods by which exercises are taught may contribute to the
extent of effectiveness achieved. For example, verbal instruction of PFM exercise to
women with and without incontinence was found ineffective 60% of the time, and led to
incorrect techniques that could potentially increase symptoms.136 Correct contraction can
be verified by biofeedback or manual palpation. In women, biofeedback can be obtained
using small electrodes placed around the anus or by using an internal, vaginal electrode.
Using biofeedback allows women to see almost instantly their muscle output during
exercise. Incontinence rates obtained with the use of biofeedback range from 54% to
95%.137 For biofeedback to be successful, four conditions must be met: an easily
measurable and detectable response, the ability to detect change in that response, a cue to
control need, and a motivated client who is actively involved. Randomized controlled
trials have found biofeedback assisted PFM exercise to be effective in reducing SUI.
Women with SUI performing biofeedback-assisted PFM exercise 1 time per week for 8
weeks reported a significant decrease in UI episodes when compared to women in a no
treatment control group.18, 108
Although the effectiveness of biofeedback-assisted PFM exercise for women with
SUI is established when compared to no treatment, conclusions regarding its efficacy
when compared to PFM exercise alone are divided. Women with SUI performing
biofeedback-assisted PFM exercise weekly for 8 weeks reported a similar decrease in UI
episodes and percentage of improvement as those performing PFM exercise alone during
8 weekly sessions.24 Aukee and colleagues reported similar results in women with SUI
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using a home biofeedback unit.23 In this study, one group received 5 supervised exercise
sessions with a physical therapist over 12 weeks plus practice at home with a home
biofeedback unit. The intervention for the comparison group did not include use of a
home biofeedback unit. Groups did not differ in urine leakage or quality of life outcomes.
The biofeedback group only showed a significant change in mean PFM EMG
(electromyography) activity measured supine.23 No other differences were noted with
reference to EMG activity in sitting or standing. This result may have reflected a training
effect; those that used biofeedback may have done so in the supine position. As the study
did not include tests for PFM force output, it cannot be concluded that women using
biofeedback achieved greater strength than women not using biofeedback. Moreover,
Pages and colleagues found no significant differences in incontinent episodes between
women with SUI that participated in group exercise 5 times/ week for 4 weeks that
emphasized PFM exercise compared to women who received individual therapy sessions
using biofeedback 5 times per week for 4 weeks.25 After 4 weeks, both groups of women
continued the exercise program once daily at home for 2 months. Both groups
demonstrated similar significant improvements in frequency of incontinence, PFM
strength, and closure of the introitus.
Based on the literature, PFM exercise with biofeedback is not more efficacious
than PFM exercise alone. However, PFM training with biofeedback may be a clinically
useful and acceptable treatment for some women. A practical strategy may be to initiate
PFM exercise with biofeedback for those who have difficulty understanding how to or
are unable to contract their PFMs.

56

2.9.3 SUI: PFM exercise and electrical stimulation
Electrical stimulation is another intervention used by physical therapist to manage
UI. The physiological goals of electrical stimulation (ES) are to build muscle
hypertrophy, to normalize reflex activity of the lower urinary tract, and to increase
circulation to muscles and the capillary system.137 The rationale for ES as an intervention
for SUI is based on evidence that has shown ES of the pudendal nerve improves urethral
closure by activating the PFM.138 It may also increase conscious awareness of the action
of these muscles to yield an improved ability to perform a voluntary muscle contraction.
Results are mixed regarding the efficacy of ES in the treatment of SUI. Sand and
colleagues found that women with SUI using home ES twice daily for 12 weeks reported
significantly less UI based on pad test and voiding diary outcomes when compared to
women using a sham device. Additionally, those using ES demonstrated significantly
improved PFM strength compared to the sham group.26 On the contrary, Brubaker et al.
reported no differences between women with SUI who used ES daily for 8 weeks
compared to those who used a sham device based on changes in incontinent episodes,
quality of life scores, and urodynamic diagnosis of SUI. 139 Similarly, women with SUI
using home ES one hour per day for 8 weeks demonstrated similar PFM strength, urine
leakage based on pad test, and quality of life as women using sham ES.140
Investigations that compared ES to PFM exercise, or combined ES and PFM
exercise, have not shown superior results to PFM exercise used alone in the treatment of
SUI. Goode et al. compared outcomes in women with SUI utilizing PFM training, PFM
training and home ES, or a control condition consisting of a self-administered
incontinence booklet.16 Women who received PFM training combined with ES reported
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a mean 72% reduction in incontinent episodes. When compared with PFM exercise
alone, the addition of ES did not improve the results. However, patients’ perception of
progress was better for women receiving the ES combined with PFM exercise.
Furthermore, Bo and colleagues reported greater improvements in pad test results, PFM
strength, and subjective cure for women with SUI treated with PFM exercise compared to
those receiving PFM exercise and ES.11 According to a recent systematic review, ES did
not improve UI more than sham stimulation or PFM exercise.141 Based on the evidence,
it may be most appropriate to utilize ES for women who are initially unable to contract
their PFM. Once PFM activation is achieved, PFM exercise alone may be more
effective.29

2.10 Interventions for UUI
2.10.1 Behavioral Training
There are two general approaches to the management of UUI. The first is
behavioral training which includes PFM exercises to inhibit bladder contractions and
other urge suppression strategies. The second strategy is bladder training which focuses
on restoring normal bladder function by modifying bladder habits using structure voiding
schedules.29 Few studies have investigated the effectiveness of PFM exercise to reduce
symptoms of urgency and/or UUI thus making it difficult to understand the mechanisms
by which PFM exercise impact UUI. Aside from the potential to hypertrophy the LA
muscle, PFM training along with urge suppression strategies are believed to reduce UUI
by inhibiting bladder contractions. Shafik and Shafik investigated the role of the PFMs in
suppressing involuntary voiding in healthy controls and those with OAB and concurrent
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UUI.74 In those with OAB the bladder was filled to a volume inducing involuntary
detrusor contractions while vesical and urethral pressures were recorded. Subjects were
then asked to perform a 10 second PFM contraction. With the addition of a PFM
contraction, a significant decrease in bladder pressure and a significant rise in urethral
pressure were observed. Moreover, those with OAB did not demonstrate involuntary
voiding when incorporating the PFM contraction.74
A main component of a behavioral intervention approach to UUI is PFM training.
Once patients learn how to properly contract and relax their PFMs, they are instructed to
contract them whenever they experience urgency to suppress detrusor contractions and
prevent UUI. Urge suppression strategies also include informing patients of better ways
to control the sense of urgency. For instance, instead of rushing to the bathroom when
the urgency strikes, patients are advised to stop, sit down, relax their body, and contract
their PFM to diminish the urge. After the urgency passes, patients are told to walk to the
bathroom, but at a normal pace.
The effectiveness of behavioral training to reduce UUI has been tested in several
clinical trials. Subak and colleagues evaluated the effect of a behavioral program for
women with stress, urge, or mixed incontinence.75 The intervention consisted of six
weeks of group instruction in bladder training, PFM exercise, and the use of urinary
diaries to monitor UI episodes and voiding schedules. At 6 weeks, the behavioral
treatment group experienced a 40% reduction in mean weekly UI episodes. Moreover,
31% of women were 100% improved after behavioral therapy.75 Even though these
results are promising, there were several limitations to this study. First, PFM training
was based on verbal and written instructions, rendering it impossible to verify if PFM
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exercise was done appropriately. Second, the multi-component regimen had subjects set
new voiding schedule goals each week (referred to as bladder training). Thus, it is
difficult to ascertain which aspects of the intervention program contributed to the
successful outcomes. Finally, the subjects had stress, urge, or mixed UI. Although the
investigators state that no differences were found for type of UI, the relative small
distribution of those with UUI may not be representative of results if only those with UUI
were studied. Investigations focusing on persons with UUI and/or overactive bladder
exclusively may provide more applicable results to the population in question.
Wang and colleagues investigated the efficacy of PFM training in the
management of overactive bladder with accompanying UUI.76 Thirty-eight percent of
subjects performing PFM exercise three times daily for 12 weeks reported a 100%
resolution of UUI. The exercises were prescribed based on the results of an evaluation by
a physical therapist. Specifically, the physical therapist utilized Laycock’s PERFECT
scheme to grade PFM strength. This schema grades the subjects’ power (P), endurance
(E), number of repetitions (R), and number of fast (1-second) contractions (F).
Additionally, every (E) contraction (C) is timed (T). Thus, subjects were performing both
fast and slow contractions with the repetitions and intensity individually based on
performance at initial evaluation. Additionally, the subjects were instructed to contract
their PFM during an urge to void, thus incorporating the urge suppression strategy.76 The
generalizability of results of this investigation however, is limited. Women performed
exercises at home and did not receive ongoing supervision. Thus, the investigators did
not include a process for verifying that the subjects were indeed performing PFM
exercise correctly. Additionally, Wang reported women adhered to exercise for only 14.5
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days instead of the intended 84 days of training. Yet, it is promising that the investigators
found positive results utilizing a home exercise program even with poor compliance.
Thus, one would expect a supervised PFM exercise protocol to yield greater exercise
adherence and UI outcomes.
Women with UUI participating in a home exercise program and four clinical
visits over twelve weeks reported significant improvements in UI episodes per day, and
improvements in nighttime frequency, PFM strength, and urge score on a leakage
index.142 Specifically, women with UUI reported a 35% decrease in the number of UI
episodes per day. Women were instructed to perform PFM exercises twice a day for 5
minutes each session. They were to begin with 4-second contractions and progress to 8second contractions. In addition to the home exercise program, subjects were evaluated
in the clinic at 4, 8, and 12 weeks. During these visits, they were instructed on increasing
exercise efficiency and incorporating the PFM contraction into daily life.142 Although the
intervention was focused on home exercise, the additional clinic visits served to reinforce
correct PFM contraction and progress exercises which may have attributed to significant
improvements in both subjective and objective measures. This study also included a
long-term follow-up. At 6-months post-intervention, 50% of those who completed the
treatment described their progress as excellent or good and desired no further treatment.
Another common treatment for UUI is drug therapy. Burgio and colleagues
performed a prospective randomized clinical trial that compared the effectiveness of a
behavioral intervention to drug therapy for UUI.143 All subjects received 4 clinic visits at
2-week intervals during an 8-week period. The behavioral training group was instructed
in PFM exercise with the use of biofeedback and urge suppression strategies, Women
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were provided a home exercise program consisting of 45 pelvic muscle exercises daily.
The drug group received oxybutynin, a commonly prescribed drug for UUI, and the
control group only attended clinic visits. Behavioral training resulted in a mean 80.7%
improvement in UUI episodes, and was significantly more effective than drug treatment
(68% improvement) and the control condition (39% improvement). Of the women in the
behavioral training group, 30% reported 100% improvement. Additionally, Burgio et al
demonstrated women in the behavioral group achieved increased bladder capacity by 17
mL. Thus, in this group of community dwelling women with UUI, behavioral training
(including PFM exercise) was found to be more effective at improving patient’s
perception of incontinence than drug therapy or a control group. Only a relatively small
percentage of patients in the behavioral treatment group indicated they would like to
receive another form of treatment (14%), while much larger proportions in the drug
(75%) and control groups (75%) desired another form of treatment at the conclusion of
the study.144 According to commentary in the Cochrane Review discussing Burgio’s
study, querying subjects about their desire for additional treatment may yield richer
information than asking about cure rates.17 This type of question may help clinicians
between patients who are better and satisfied from those who are better but not
sufficiently so to be satisfied with the treatment outcome. Burgio’s protocol utilized an
individualized approach to PFM training as well as structured, supervised clinic visits
which may attribute to the large success in the study.

The clinician determined the

subjects’ level of fatigue when performing the PFM exercises and prescribed the
appropriate intensity level for the PFM contraction. This approach parallels common
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practice by physical therapists who prescribe exercises based on examination findings of
the patient’s performance.

2.10.2 UUI: PFM exercise and Biofeedback
The effectiveness of PFM exercise as an intervention for UUI may be enhanced
by the use of biofeedback. Women with OAB and associated UUI that participated in a
graded PFM home exercise regimen for 12 weeks, along with 4 clinic visits that included
biofeedback, reported a 57% decrease in the number of UI episodes per week.145 This
study suggests that this particular protocol, which utilized biofeedback, is an effective
treatment for women with overactive bladder. The study could not determine if the
addition of biofeedback was beneficial because it lacked a comparison group.
Burgio and colleagues investigated behavioral training with and without
biofeedback for the treatment of UUI.144 The behavioral training with biofeedback group
underwent 4 clinic visits at 2-week intervals for 8 weeks and utilized biofeedback in the
clinic to assist with PFM exercises. Additionally, subjects were taught urge suppression
strategies and a home exercise program. The behavioral training only group utilized the
same protocol but instead of biofeedback during the clinic visits, received verbal
feedback based on vaginal palpation. The control group utilized a self-administered
behavioral program booklet. All groups experienced a reduction in UI frequency, with
the biofeedback group having a 63% decrease; behavioral training group a 69% decrease;
and the control (booklet) group having a 38% decrease. Thus, the treatment groups had
greater UI reduction compared to the control group by 40-55%. Bladder capacity was
improved in all 3 groups, with the biofeedback group demonstrating a 42% greater
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improvement than the control group; and the behavioral group demonstrating a 23%
greater improvement than the control group. Moreover, patient satisfaction was higher in
the behavioral training alone and the biofeedback groups. Patient satisfaction included
comfort with treatment, satisfaction with progress, and less activity restriction. Thus,
from this particular study of women with UUI, both biofeedback and vaginal palpation
were effective means of teaching PFM exercises. Furthermore, both treatment groups
demonstrated improved outcomes when compared to the control group. Additionally,
women with overactive bladder participating in PFM exercises with and without
biofeedback demonstrated similar improvements regarding UI episodes, voiding
frequency, urgency episodes, and number of continence pads used.76 However, the
biofeedback group demonstrated significantly higher quality of life scores based on the
total score of King’s Health Questionnaire. No significant differences were noted when
comparing the subscales of this questionnaire between the groups.
The studies cited above and a recent meta-analysis 146 strongly suggest that the
addition of biofeedback may not produce better results compared to PFM exercise alone.
However PFM with biofeedback is a common and clinically acceptable intervention for
women with UUI. A practical strategy may be to initiate PFM exercise with verbal or
tactile feedback, and utilize biofeedback only for those who do not respond to this form
of teaching or do not progress as anticipated.

2.10.3 Bladder Training
The second main approach for treatment of UUI is bladder training. Bladder
training focuses on restoring normal bladder function by changing voiding habits,
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specifically decreasing voiding frequency and increasing bladder capacity.147 When a
woman has UUI, she experiences an overwhelming urgent sensation to void thereby
leading to frequent voids, decreased bladder capacity, and detrusor overactivity.
Ultimately, this cycle makes it very difficult for the patient to suppress bladder
contractions. Bladder training attempts to break this cycle by having the patient resist the
sensation of urgency in order to postpone urination and gradually increasing the voiding
interval. Subsequently, bladder capacity is increased and detrusor overactivity
minimized. The key component of bladder training is helping the patient set a reasonable
voiding schedule with an eventual voiding interval goal of 3 to 4 hours. Patients are
instructed to empty their bladder on waking and at the end of each time interval
subsequently during the day. If they have to void sooner, they are told to use urge
suppression techniques (i.e., distraction, relaxation, or self-affirming statements) to get
them through to the next scheduled voiding time. Specific urge suppression examples
include having the patient concentrate on a task they want to complete (i.e. making
dinner), take 5 deep breaths, or perform 5 PFM contractions quickly.147 The
effectiveness of bladder training has been demonstrated in a randomized trial by Fantl
and colleagues. These investigators found bladder training alone reduced UI episodes by
57% and the volume of fluid loss by an average of 54% in older women compared to an
untreated control group. A remarkable finding in this study was that the improvement in
UI episodes occurred in absence of urodynamic improvement.148
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2.11 PFM exercises and the Transverse Abdominus connection
There is a growing body of evidence that suggests a relationship between the
PFMs and transverse abdominus (TA) muscle. Specifically, there appears to be a
concurrent increase in TA muscle activity with PFM contraction. Neumann and Gill
demonstrated a 66% increase in normalized TA activity recorded by intramuscular EMG
when healthy women positioned supine were asked to perform a PFM contraction.149
Similarly, Sapsford and colleagues demonstrated an increase in normalized intramuscular
TA EMG amplitude between 32-42% when 7 healthy women performed a maximal PFM
contraction in supine.150
Since a concurrent increase in TA activity occurs with PFM activity, it may be
logical to assume a reversal relationship; specifically, that a concurrent increase in PFM
activity occurs with TA activity. When 6 healthy women and 1 man performed a TA
contraction in supine, PFM EMG activity, measured using a vaginal or anal surface
electrode, increased above the resting level. Subjects performed different intensities of
the TA contraction (gentle, moderate, strong), and the concurrently PFM activity
increased in gradation of the different TA intensities. Moreover, the PFM activity
recorded during a strong TA contraction did not differ from that recorded while subjects
strongly contracted the PFM in isolation.151 Similarly, Neumann and Gill149 and
Sapsford150 demonstrated increased PFM activity when healthy women performed a TA
contraction in supine. Interestingly, one subject in Sapsford’s study inadequately
performed the TA contraction, achieving only minimal intramuscular TA EMG activity.
However, this subject demonstrated an 8% increase in PFM activity 150 suggesting that a
less than ideal TA contraction may coincide with a small rise in PFM activity.
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In a theoretical paper, Sapsford proposed that weak abdominal muscles may relate
to the development of SUI.71 Sapsford noted that during coughing and nose-blowing, the
abdominal wall of women with SUI bulges forward, especially when they are in a
slumped supported position, without pretensioning of the abdominal muscles. In
comparison, healthy women will pull their abdomen inward and contract their PFMs to
increase intra-abdominal pressure to maintain continence.71, 150 Other recent studies
confirm that PFM activity is influenced by sitting posture in women with and without
SUI. Specifically, PFM activity was significantly decreased in slumped supporting
sitting verses upright sitting in healthy women and those with SUI, but a significantly
greater decrease was noted in those with SUI. Additionally, women with SUI
demonstrated a trend for increased activity in the superficial rectus abdominus in both
slumped sitting and upright sitting. Activation of the rectus abdominus may increase the
intra-abdominal pressure, thus making it more difficult for women with SUI to maintain
continence during activities that elevate intra-abdominal pressure. The increased activity
of the rectus abdominus was not observed in continent women which suggests that
women with SUI may demonstrate altered abdominal muscle recruitment.72 Thus,
Sapsford proposed a rehabilitation program for women with SUI that utilizes the
abdominal muscles to initiate PFM activity. 71 Inclusion of TA exercises into the
intervention plan for women with SUI may contribute to improved PFM recruitment and
better outcomes. However, this approach has not been investigated for efficacy in
improving outcomes for women with SUI.
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2.12 Lifestyle Measures to decrease SUI and UUI
2.12.1 Caffeine and Fluid Intake
Anecdotal reports have led to a list of potential dietary triggers for UI including
chocolate, citrus fruits and juices, tomatoes and tomato-based products, vinegars, dairy
products, aspartame, and spicy foods. However, none of these have been linked
scientifically as bladder irritants.62 Caffeine and overall fluid intake however have been
investigated for their impact on UI.
Swithinbank and colleagues investigated the effect of fluid manipulation in
women with SUI and OAB.152 The four week study included a baseline week followed by
3 weeks of caffeine restriction and alterations in fluid intake. During week 2, participants
drank normally, without fluid manipulation. During week 3 or 4, participants either
increased decaffeinated fluids to 20 cups per day or decreased fluids to 5 cups per day.
Decreasing fluid intake significantly improved urinary frequency, urgency, and
incontinence, and quality of life in those with OAB; and decreased urinary frequency in
women with SUI. Alternatively, increasing fluid intake significantly increased voiding
frequency, UI episodes, and urgency in those with OAB compared to baseline and the
week of decreased fluids. In those with SUI, increased fluid intake significantly
worsened UI episodes when compared to the week of decreased fluid.152 In another
study, women and men with OAB who participated in a prospective, cross-over trial were
required to alter fluid intake by drinking 25% and 50% less than baseline, as well as 25%
and 50% more than baseline.153 A significant reduction in urgency, frequency, and
nocturia occurred when subjects decreased their fluid intake by 25%. As expected, a
significant increase in daytime UI episodes was reported when fluid intake was
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increased.153 Conversely, Dowd and colleagues reported no improvement in UI
symptoms with fluid manipulation. However, a significant proportion of participants did
not adhere to the protocol.154 Similarly, Dallosso showed no association between total
fluid intake and either OAB or SUI in women aged >40 years. The literature is
conflicting regarding the efficacy of fluid manipulation in treatment of UUI. It appears
that decreasing fluid intake may decrease symptoms of UUI more so than symptoms of
SUI. Therefore, is reasonable to advise patients to maintain adequate fluid hydration to
prevent dehydration.
Although the stimulatory effect of caffeine has been shown to directly influence
the bladder by increasing bladder pressure during filling,155 altering caffeine intake does
not necessarily decrease UI symptoms. Swinthinbank and colleagues also investigated the
role of caffeine restriction in 110 women with SUI and OAB.152 Changing from caffeine
containing to decaffeinated drinks produced no improvement in urinary symptoms.
Similarly, Dowd found no association between caffeine intake and UI episodes in 32
women >50 years.154 After controlling for other lifestyle factors, Dallosso showed no
relation between caffeine and OAB or SUI.57 Although evidence regarding effectiveness
of caffeine restriction is lacking, there is an association between caffeine and OAB.56, 155
Arya and colleagues reported a significant association between high caffeine intake
(>400mg) and OAB.56 An 8-ounce cup of brewed/drip coffee has a caffeine content
range of 71-280mg156 or a mathematical mean of 175.5mg per cup. Thus, consuming 2.5
cups of coffee per day would yield a high caffeine intake of >400mg and for those with
OAB, consuming high amounts of caffeine should be considered a risk factor.
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2.12.2 Weight Loss
There is a growing body of evidence supporting weight-loss for overweight and
obese women as a lifestyle intervention for UI. Obese and overweight women with UI
participating in an intensive 6-month weight-loss program consisting of diet, exercise,
and behavior modification reported significantly less UI symptoms when compared to
controls.157 Women in the weight-loss group lost a mean of 8% of body weight, and
reported significantly less UI episodes and smaller volume of urine leaks. Moreover,
when compared to controls, women in the weight-loss group reported less UI symptom
impact and higher satisfaction with the improvement in continence status.157 Overweight
pre-diabetic women participating in a weight-loss program demonstrated significantly
less UI episodes than women taking an anti-diabetic drug or placebo drug.158 Women in
the weight-loss program lost an average of 3.7% of body weight (7.49 pounds) and
reported significantly less weekly UI episodes than those in the drug or placebo groups.
After adjusting for baseline hormone therapy use, general health status, and postchallenge glucose categories, women in the weight-loss group had significantly lower
odds of weekly UI compared with women in the placebo group (OR 0.76; 95% CI 0.610.95).158 It appears that even small amounts of weight loss in overweight and obese
women may significantly decrease UI and improve patient perception of UI symptoms.
Thus, a decrease in UI episodes may be another benefit among the numerous health
benefits associated with weight reduction.
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2.13 Bowel Dysfunctions
2.13.1 Constipation
The most common interventions for constipation include increasing fluid intake,
increasing dietary fiber intake, and promoting bowel motility via abdominal massage.
Based on a review of four studies,36-39 Muller concluded that there was no conclusive
scientific evidence to support that constipation can be successfully treated by increasing
fluids.159 Of the reviewed studies, one found fluid intake volume to be similar in
constipated subjects and controls. Another study that examined whether constipation
could be improved by increasing fluid intake reported no changes in subjects’ stool
frequency, consistency, or ease of defecation. Finally, another study that examined the
effect of increasing fluid intake in constipated patients reported increased stool
frequency. However, subjects drank mineral water containing magnesium and other ions
that may have acted as a light laxative.159
Dietary fiber has been recommended for improved bowel function.159 The
National Academy of Sciences Institute of Medicine recommends that female adults over
50 years of age have 20-25 g of fiber daily. Most Americans consume only 5-10 g daily.
There are 2 types of dietary fiber. Soluble fiber is thought to be beneficial in lowering
blood cholesterol and decreasing plaque-forming low density lipoprotein. Insoluble fiber
increases fecal volume density by slowing digestion, colon distention, peristalsis, and
increased water absorption.160 Women with constipation who supplemented their diet
with high-fiber cereal reported significantly improved constipative symptoms, as well as
significantly decreased use of laxatives, and the need for vaginal and/or perineal
splintings to assist bowel movements.160 The 30 women in the study also significantly
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decreased their caffeine intake compared to baseline which may have contributed to the
favorable results. Muller cautioned that a diet low in fiber should not be assumed to be
the cause of constipation, but may be a contributory factor.159 Patients with more severe
constipation may experience gas production from fiber metabolism which limits
effectiveness of fiber. Moreover, a review of four studies that examined dietary fiber
intake by people with chronic constipation, found no differences compared to controls.159
For patients with a specific type of constipation, slow-transit constipation,
abdominal massage may be beneficial. Slow-transit constipation is due to decreased
neuromuscular function of the colon; therefore, interventions are aimed at increasing gut
mobility. Klauser and colleagues reported that abdominal massage performed three times
per week for three weeks did not improve slow-transit constipation.161 However, a case
study utilizing a more frequent approach yielded positive results. Harrington and
Haskvitz instructed an 85-year old woman with slow-transit constipation in bowel
management, as well as a 10-minute home abdominal massage program.40 After five
visits over a 13 week period, the patient reported a return of normal bowel frequency
without the need to strain or use digital evacuation.

2.13.2 Fecal Incontinence
Fiber intake also plays a role in the management of FI by promoting increased
stool consistency. Subjects with FI that took fiber supplements for 31 days demonstrated
a significant decrease in the percentage of incontinent stools, and an improvement in
stool consistency compared to a placebo control group.162 However, fiber supplements
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can potentially worsen diarrhea by increasing fermentation of inabsorbable fiber in the
colon.45
Physical therapy interventions for FI include PFM exercise, biofeedback, and
electrical stimulation.41 PFM training is used to improve coordination of muscle
contractions, improve muscular strength, and increase awareness and isolated contraction
of the PFMs. The use of biofeedback and electrical stimulation augment such goals as
discussed previously. In addition, biofeedback can be used for rectal sensitivity and
coordination training.43 The rationale for rectal sensitivity training is to enhance
detection of a lower stool volume in the rectum to promote earlier opportunity for a
patient to find a toilet and/or contract their PFMs to delay or prevent FI. In rectal
sensitivity training, a rectal balloon is filled with air or water to imitate rectal contents,
and the patient is asked to report first sensation with rectal filling. Repeated re-inflations
of the balloon are performed to the determined volume with the goal of teaching the
patient to feel the distension at progressively lower volumes. In coordination training,
typically a three balloon system is utilized: one situated in the rectum, and the second and
third (recording balloons) are placed in the upper and lower anal canal. When the rectal
balloon is distended, the patient is taught to counteract the momentary anal relaxation by
voluntary squeezing the PFM until the relaxation period is over.43
Norton and Kamm investigated PFM exercise and biofeedback in 100 patients
with FI.163 Patients performed PFM exercise with biofeedback for a median of 4
sessions; and for those who demonstrated high stool threshold volumes, rectal sensitivity
training was also included. Forty-three percent of subjects regarded themselves as
“symptomatically cured” while 24% were “improved” after treatment. Patients with
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structurally intact sphincters (as measured by anal endosonography) were most likely to
benefit from treatment, although some with structural changes also improved.163 In a
systematic review, Palsson and colleagues concluded that biofeedback for FI provides a
significantly higher probability of successful outcome than standard medical care, and
should be viewed as a valuable adjunct to medical management.164 On the contrary, the
Cochrane review regarding biofeedback and/ or PFM exercise for FI concluded that the
limited number of clinical trials combined with their methodological weaknesses do not
allow for a definitive assessment of the role of biofeedback and/or PFM exercise in the
management of FI. However, there were suggestions that rectal sensitivity training
improves FI more than sham training.43 As biofeedback and PFM exercises are safe and
certainly more conservative compared to surgical options, the American College of
Gastroenterology Practice Parameter Committee contends that biofeedback is an effective
treatment in patients with weak sphincters and/or impaired rectal sensation.45
A Cochrane review of electrical stimulation (ES) as an intervention for FI
concluded a lack of evidence to judge whether ES is efficacious. 147 Norton and
colleagues found no differences regarding FI episodes, patient satisfaction, or
manometric squeeze pressures following 8 weeks of daily anal ES compared to sham
stimulation in 90 patients with FI.148 Ostenberg and colleagues compared surgery with
ES in patients with FI.44 Electrical stimulation lasted 20 minutes for a total of 12 sessions
over a period of 4-5 weeks. Compared to baseline status, those receiving ES
demonstrated significantly improved incontinence scores on a condition-specific
questionnaire and less absorbent pad use at 3, 12, and 24 months after treatment.
However, manometric squeeze measures were unchanged. Surgery was superior to ES at
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3 months but not at 12 or 24 months.44 Conclusions regarding the effectiveness of ES for
FI are unclear. Recent practice guidelines by the American College of Gastroenterology
suggest that ES should be considered experimental and merit controlled clinical trials.45

2.14 Interventions for Chronic Pelvic Pain
Physical therapists use a variety of techniques for treatment of musculoskeletal
causes of CPP. Treatment is aimed at reducing or eliminating the impairments found
during the initial examination. Table 2.1 outlines common physical therapy interventions
as well as the impairments that the intervention attempts to influence.
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Table 2.1: Physical therapy interventions utilized in the treatment of CPP
Physical Therapy Intervention

Impairment

Biofeedback130, 132

Weak PFM, Hypertonic PFM

Electrical Stimulation130, 132

Pain in hip, lumbar, or pelvic region;
Hypertonic PFM, Weak PFM

Superficial Heat and Cold Modalities130

Pain in hip, lumbar, or pelvic region

Joint mobilization128 or Muscle energy

Restricted joint motion of the hip and/or

128

techniques

pelvis

Soft tissue mobilization,127, 130 Myofascial

Hypertonic PFM; Spasm of hip, lumbar,

release,125, 128, 130 Trigger Point release125,

or pelvic musculature; Trigger points

130

externally or internally

Connective and scar tissue release130, 132

Hypomobile scars due to abdominal
and/or pelvic surgery (i.e. episiotomy,
cesarean section)

Vaginal dilation132, 165

Hypertonic PFM and/or introitus pain

Stretching / Range of motion techniques132 Shortening of hip, low back, or pelvic
muscles
Therapeutic Exercise132 which may

Weak muscles of the hip, low back, or

include postural exercises130

pelvic region

2.15 Outcomes
To assess if interventions are effective, outcome questionnaires are needed to
quantify patient perceptions of symptom improvement. Because the clinical presentation
of women with UI is varied, it is necessary to utilize outcome measures that incorporate
the myriad of co-existing pelvic symptoms.
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2.15.1 Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire
Generic health-related quality of life (QOL) instruments such as, the Medical
Outcomes Survey Short-36 and the Sickness Impact Profile, have been used to examine
the QOL in women with UI. Although generic health-related QOL measures have the
advantage of comparing results among groups, such instruments may lack the sensitivity
to measure the unique aspects of a specific disease and its impact on a patient’s QOL.
The Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact
Questionnaire (PFQI) are condition specific quality of life instruments that assess the
impact of urinary, bowel, and prolapse symptoms on a woman’s QOL. Although there
are several standardized quality of life instruments specific to UI symptoms,49, 166 only
the PFDI and PFIQ encompass the ability to assess co-existing disorders of UI,
specifically, bowel dysfunction and POP. Because several pelvic floor disorders may coexist in the same woman,31 the use of instruments that assess the whole spectrum of
interrelated symptoms is essential when evaluating the efficacy of treatment
interventions.
Both the PFDI and the PFIQ are based on the structure and content of two widely
used condition-specific health related QOL instruments for women with lower urinary
tract symptoms: the Urinary Distress Inventory (UDI) and the Incontinence Impact
Questionnaire (IIQ).166 The UDI contains 19 symptom questions related to lower urinary
tract dysfunction including urinary frequency, UI, nocturia, incomplete bladder emptying,
and lower abdominal pressure. The UDI measures symptoms and the perceived degree of
bother associated with each symptom. The IIQ is a 30-item questionnaire that measures
the degree to which UI impacts social relationships, physical activities, travel, and
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emotional health. Data on the reliability, validity, and sensitivity to change of these
measures demonstrate that they are psychometrically strong.166 Both the UDI and IIQ
subscales demonstrate acceptable internal consistency reliability with Cronabach’s alpha
coefficients for the UDI subscales ranging from 0.48-0.77; and for the IIQ ranging from
0.87-0.90. Only one subscale of the UDI, stress symptoms, demonstrated reliability
(0.48) below the desired range recommend (0.7-0.95) by Portney and Watkins.167 When
compared to well-validated generic health related QOL measures including the RAND-36
Health Survey, the Centers for Epidemiological Studies Depression Scale, the Medical
Outcomes Study measure of Social Support 1992, and the Profile of Mood States, the
UDI and IIQ scores generally correlated well with scores on these measures verifying
convergent validity. For the IIQ, 15 of the 16 correlations between the four IIQ subscales
and the four generic measures were significantly significant with correlations ranging
from 0.37 to 0.52, mean = 0.37. For the UDI, 9 of the 12 correlations between the three
UDI subscales and four generic measures were significant with correlations ranging from
0.09 to 0.40, mean = 0.22. Such moderate correlations demonstrate that the IIQ and UDI
measure more than general health constructs. Moreover, the UDI and IIQ are responsive
to change, and significantly correlate with clinical measures of condition severity
including number of incontinent episodes and the amount of urine leakage as measured
by a pad test.166
All questions from the UDI and IIQ are included in the PFDI and PFIQ along
with additional items regarding POP and bowel dysfunction.168 These additional items
were included to ensure that the full range of QOL issues of women with pelvic floor
dysfunction were addressed. The PFDI has 46 items and contains 3 subscales: the UDI,
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Pelvic Organ Prolapse Distress Inventory (POPDI), and the Colorectal-anal Distress
Inventory (CRADI). Respondents are asked if they experience symptoms and if so, to
rate the degree on which they are bothersome on a scale from 1 (not at all) to 4 (quite a
bit). The PFIQ has 93 items and contains 3 scales: the Urinary Impact Questionnaire
(UIQ), the Pelvic Organ Prolapse Impact Questionnaire (POPIQ), and the Colorectal-anal
Impact Questionnaire (CRAIQ). Each subscale contains 31 items with 30 of these items
identical to the questions in the IIQ referring to the degree to which symptoms affect
social relationships, physical activity, travel, and emotional health. One question was
added to each subscale to assess the effect of bladder, bowel, or vaginal symptoms on the
patient’s relationship with her husband or intimate partner. The psychometric properties
of the PFDI and PFIQ were assessed in study of 100 women (mean age 56 years) with
pelvic floor dysfunction who underwent a standard pelvic floor dysfunction evaluation
including a structured interview, physical examination that included POP quantification,
and urodynamic evaluation. Additionally, women kept a 1-week prospective bladder and
bowel diary. Subjects completed the PFDI and PFIQ at their initial visit and completed it
again 7 days later. The PFDI and PFIQ demonstrated good internal consistency, with
Cronbach’s α reported as 0.88 for the overall PFDI score and 0.98 for the PFIQ. Testretest reliability was good for both instruments with the ICCs of 0.87 and 0.86 for the
PFDI and PFIQ respectively. Content validity was confirmed by an expert panel.
Finally, content validity of the PFDI and PFIQ was tested by comparing objective data of
symptom severity, responses to structured interviews, and final pelvic floor diagnoses
with the appropriate scales of each instrument. POP subscales of the PFDI and PFIQ
positively correlated with a validated measure of prolapse severity and two pelvic floor
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conditions associated with prolapse (voiding dysfunction and defecatory dysfunction).
Colorectal subscales of the PFDI and PFIQ correlated with one measure of symptom
severity (number of FI episodes per week), two symptoms associated with abnormal
defecation (hard straining and perineal splinting), and three diagnoses of bowel
dysfunction (FI, defecatory dysfunction, and rectal prolapse). Urinary subscales of the
PFDI and PFIQ significantly correlated with three measures of symptom severity from
the bladder diary including number of UI episodes per week, number of pads used per
week, and the average daytime voiding interval.168 Thus, the PFDI and PFIQ are valid
and reliable instruments for women with pelvic floor disorders.
Although the PFDI and PFIQ are psychometrically strong, the time it takes
patients to complete the questionnaire (23 minutes (+11 minutes)) may limit their clinical
utility.168 Barber and colleagues developed two short form versions of these
questionnaires that are valid, reliable, and responsive to change.78 The short form
versions (PFDI-20 and PFIQ-7) were tested in 45 women (mean age 59 years) having one
or more pelvic floor disorders including UI, voiding dysfunction, ≥stage 2 pelvic organ
proplape, defecatory dysfunction, and/or rectal prolapse; and were scheduled for
reconstructive pelvic surgery or continence surgery. Preoperatively, subjects underwent a
standardized evaluation consisting of a structured urogynecologic history, physical
examination with POP quantification; and they completed the Medical Outcomes Study
Short Form-36 (SF-36) and the short and long forms of the PFDI and PFIQ. The short
versions demonstrated significant correlations with the long versions for both the PFDI
and PFIQ with ICCs ranging from 0.86-0.93 and 0.94-0.96, respectively. Additionally,
each of the PFDI-20 and PFIQ-7 subscales demonstrated good to excellent test-retest
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reliability with ICC values between 0.70 and 0.91. To assess the responsiveness of the
PFDI and PFIQ, subjects completed the instruments and the SF-36 again 3 to 6 months
after the surgery. The instruments were responsive to change as demonstrated by
significant improvements pre- to post-surgery in PFDI-20 and PFIQ-7 scores.
Additionally, the PFDI-20 demonstrated moderate to excellent responsiveness with an
effect size and standardized response mean (SRM) values ranging from 0.70 to 1.28,
repectively. The PFIQ had moderate responsiveness with an effect size of 0.67 and SRM
of 0.63.78 For both the effect size and SRM, a value of 0.5 to 0.7 is considered moderate
responsiveness, 0.80 to 1.00 is considered good, and more than 1.0 is considered
excellent.169 In contrast, the majority of the scales of the SF-36 were not responsive to
change. Moreover, the summary scores of PFDI-20 and PFIQ-7 significantly correlated
with subjects’ global index of improvement score, indicating that the instruments are able
to differentiate between those who got “better” from those who got “worse” (C-statistic
0.96 and 0.88, respectively, where 1 indicates a perfect test and 0.56 indicates a test with
no discriminative ability).167,154 Based on comparisons to global index of improvement
scores, Barber and colleagues determined that a ≥ 45 point change in the PFDI-20
summary score and a ≥36 point change in PFIQ-7 summary score were clinically
meaningful changes in QOL life in patients undergoing surgery for pelvic floor
dysfunction.78

2.15.2 Patient Global Impression of Improvement
Global indices are utilized in order to obtain a very simple and direct appraisal of
the patient perceptions of improvement. In contrast to QOL and symptom distress and/or
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impact questionnaires, a global index usually contains one question that asks the patient
to rate the severity of the condition or the response of the condition following therapy.
The Patient Global Impression of Improvement (PGI-I) is a global index used in recent
research trials to assess patient perception of treatment intervention.170-173 The PGI-I has
been shown to have good construct validity in women with SUI.77 Yalcin and Bump
demonstrated significant correlations between the PGI-I and frequency of UI episodes,
urine leakage on pad test, and a validated condition-specific QOL questionnaire in a
prospective study of women assigned to drug therapy or placebo for UI.77

2.15.3 Constipation Scoring System
Although the PFDI-20 and PFIQ-7 are comprehensive instruments to evaluate
women with pelvic floor dysfunction, the subscales assessing bowel dysfunction
primarily refer to FI. Women with UI report often report co-existing constipation.33, 34
Inclusion of a questionnaire assessing constipation symptoms is necessary to determine
the effectiveness of interventions. The Constipation Scoring System (CSS) is a valid
instrument that correlates with objective physiologic findings in constipated patients.
Agachan and colleagues reported that the CSS demonstrated convergent and divergent
validity in 185 women and 47 men (mean age 65 years) with constipation confirmed via
physiological tests.79 Subjects’ scores on the CSS were significantly correlated with anal
and colorectal physiologic studies. Agachan and colleagues also demonstrated divergent
validity of the CCS using 2 groups of subjects, those with and without constipation
confirmed by physiologic studies. CSS scores differentiated between those that were
constipated and were not constipated with 96% accuracy. Advantages to the CSS are that
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it is valid, and that it includes only 8 items. The reliability, responsiveness, or sensitivity
to change of the CSS has not been determined.

2.15.4 Female Sexual Function Index
The Female Sexual Function Index (FSFI) is a 19-item questionnaire that
measures sexual function across 6 domains: desire, arousal, lubrication, orgasm,
satisfaction, and pain. FSFI items are rated on a 5 point Likert-type scale with higher
scores indicating better sexual function.80 The maximum possible score for a domain is
6.0. A full scale score can range from 2.0 to 36.0, and is obtained by adding the 6 domain
scores. The FSFI has been reported to have good internal consistency, reproducibility,
and discriminative validity.80 Rosen and colleagues reported acceptable internal
consistency reliability for all six FSFI domains with Cronbach’s α values of 0.82 – 0.97
in women aged 21-69 years with and without Female Sexual Arousal Disorder. Testretest reliability was also confirmed with significant Pearson product-moment correlation
coefficients ranging from 0.69 – 0.91. Moreover, females with sexual function had
significantly poorer scores when compared to healthy controls, indicating that the FSFI is
able to differentiate between clinical and nonclinical populations.80 One domain, instead
of the entire questionnaire, can be administered as Rosen reported the psychometrics for
all of the specific domains. Because women with UI are at a higher risk for
dyspareunia,35 it seems prudent to include an instrument assessing sexual pain when
evaluating the efficacy of UI interventions.
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2.16 Barriers to successful physical therapy outcomes
Women seeking physical therapy for treatment of UI are typically seen one time
per week over a period of 4-8 weeks. An integral part of the patient’s intervention
program is instruction and performance of pelvic floor muscle training at home to
supplement the weekly physical therapy visits. A woman’s adherence or non-adherence
to the prescribed home exercise program may logically impact the success of physical
therapy for UI treatment.
For postpartum women, factors that may influence whether women perform PFM
exercise include education, activity level, parity, smoking status, type of child delivery,
UI status, and pelvic pain.174 Women who performed PFM at least once a week 6 months
postpartum were significantly more educated, had more children (2 children OR 1.07;
95% CI 1.09-12.26 and 3 children OR 1.45; 95% CI 1.33-1.59) and were twice as likely
to participate in a general fitness activities 3 or more times a week (OR 2.06; 95 %CI 1.32.33) than women who women who performed PFM exercises less frequently or not at
all. Additionally, women who were experiencing UI and/or pelvic pain were also more
likely to do PFM exercises. On the contrary, women who smoked daily or had cesarean
section were less likely to do PFM regularly. Rates of performance of PFM exercise at 6
months postpartum vary from 58%174- 67%.175 Reasons women gave for not initiating
PFM or for stopping PFM exercise in the 6-month postpartum period include the
rationale that exercise was unnecessary if the woman was not experiencing any UI, they
forgot to perform the PFM exercise, or that they were too busy.175
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For women with UI, PFM exercise adherence rates at 5 years vary from 10%17670%.177 Only one study investigated adherence after 15 year after cessation of PFM
training and reported that 28% of women performed PFM exercise at least weekly.178
Those that do not regularly engage in PFM exercise after cessation of formal PFM
training are at increased risk of frequency of UI episodes. Lagro-Janssen reported that
those who performed PFM exercise at five years were over 8 times more likely to report a
50% or greater decrease in the frequency of UI episodes compared to UI episodes one
year after cessation of physical therapy.179 Patients who did not perform PFM exercise at
follow-up cited lack of discipline, interference with daily activities, lack of time, and
disinterest as reasons for failure to perform PFM exercise at home.176
Studies have reported an inconsistent relationship between patient characteristics
and exercise adherence. Alewijnse and colleagues investigated predictors of long-term
adherence to PFM exercise among women with UI who sought physical therapy
treatment.180 The most striking association reported was that women who performed
PFM exercise after cessation of physical therapy were more likely to continue adherence
at one year follow-up. Additionally, women who had more frequent weekly UI episodes
before physical therapy treatment and at one year follow-up had higher adherence levels
one year after therapy than women with fewer weekly losses.180 Lagro-Janssen reported
that age, parity, severity of incontinence, and patients’ psychological characteristics such
as anxiety, did not predict successful urinary outcomes.179 On the contrary, Alewijnse
reported that the amount of urine loss per incontinent episode as well as a women’s
perception of their ability to do the exercises as recommended under various
circumstances were significant predictors of the intention to adhere to PFM exercise.181
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The discrepancy regarding the severity of incontinence in Lagro-Janssen and Alewijnse’s
studies could be explained in the fact that Lagro-Janssen defined severity as a function of
frequency of urine loss, amount of urine loss, use of protective pads, and restriction in
daily activities due to incontinence, while Alewijnse utilized a strict definition of urine
loss per incontinent episode.
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Chapter 3
Methods
3.1 Experimental Design & Setting
The first primary aim of this retrospective descriptive study was to determine the
efficacy of physical therapy interventions provided within a pragmatic setting on global
impression of improvement, pelvic symptoms, and health-related quality of life to women
with a primary diagnosis of UI. Women’s post-intervention PGI-I scores were
summarized to determine the subjects’ global impression of improvement with physical
therapy intervention. To determine the efficacy of physical therapy intervention on
pelvic symptoms, women’s pre-post intervention PFDI-20, CSS, and FSFI change scores
were analyzed. In addition, women’s pre-post PFIQ-7 change scores were examined to
determine the effectiveness of the physical therapy intervention on health-related quality
of life. The second primary aim was to determine the relationship between selected
patient-related characteristics (age, parity, race, number of comorbidities, carbonated
beverage intake, current smoking status, presence of barriers to intervention
recommendations, and number of physical therapy visits) and treatment success.
Treatment success was defined as a post-intervention PGI-I score of “much better” or
“very much better;” a reduction in pelvic symptoms (reduction in PFDI-20 score at
discharge); and improvement in health-related quality of life (reduction in PFIQ-7 at
discharge).
The secondary aim was to document the percentage of women who received 4
possible interventions. Because intervention selection may be determined by the
constellation of symptoms a woman possesses, separate percentages were calculated for 4
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symptom-based categories of women. The categories included: UI symptoms only, UI +
bowel symptoms, UI + pelvic pain, or UI + bowel symptoms + pelvic pain. Interventions
included patient education, modalities, manual physical therapy procedures, and exercise.
(See Table 3.5 for delineation of interventions).
Data for this study were obtained from the Centers for Rehabilitation Services
(CRS) Women’s Health Physical Therapy Database. Fifteen physical therapists (PTs)
from 12 different CRS clinic locations managed the care of women referred to physical
therapy services at the CRS for UI. Each physical therapist (PT) hand entered patient
data into the Women’s Health Physical Therapy Database. The locations of the 12 clinics
are delineated in Table 3.1.
Table 3.1: CRS Locations
CRS Cranberry
Rowan Towers
8050 Rowan Rd.
Suite 101
Cranberry, PA 16066
CRS Monroeville
UPMC at Oxford Drive
600 Oxford Drive
Suite 310
Monroeville, PA 15146
UPMC South Hills
1300 Oxford Dr.
Suite 1F
Bethel Park, PA 15102

CRS Harmarville
Alexander's Athletic Club
2585 Freeport Rd.
Suite 205
Pittsburgh, PA 15238
CRS Moon Township
UPMC West
1600 Coraopolis Heights Rd.
Coraopolis, PA 15108

Chippewa
2580 Constitution Blvd.
Beaver Falls, PA 15010

CRS Gibsonia
Northtowne Square
5600 William Flynn Highway
Gibsonia, PA 15044

CRS Squirrel Hill
2345 Murray Ave.
Suite 300
Pittsburgh, PA 15217
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CRS Delmont
Salem Place
6530 Route 22
Suite 100
Delmont, PA 15626
CRS Oakland
Kaufmann Medical Bldg.
3471 Fifth Ave.
Suite 1201
Pittsburgh, PA 15213
CRS-UPMC St. Margaret
Park Place at Chapel Harbor
300 Chapel Harbor Dr.
Suite 200
Pittsburgh, PA 15238
CRS McCandless
9365 McKnight Rd.
Suite 300
Pittsburgh, PA 15237

3.2 Subjects
Data from female patients with UI (of both neurogenic and non-neurogenic
origin) managed by CRS PTs between November 1, 2009-November 15, 2010 were
included for study analysis. Potential patient records were excluded from this study if the
patient:




was seen for less than 2 therapy visits;
did not complete at least one of the three initial primary outcome measures (PGII, PFDI-20, and/or PFIQ-7); and/or
reported pain with urination (indicating possible urinary infection).

In addition, women with neurogenic bladder symptoms (predominate etiology of
multiple sclerosis), who indicated that they were currently experiencing a neurological
relapse or a score of 8 (indicating a walking status of “bedridden”) on the PatientDetermined Disease Steps were not eligible for inclusion in the study. The PatientDetermined Disease Steps is a disease-specific measure for individuals with multiple
sclerosis used to assess mobility based on the patient’s own perception of her walking
ability. For patients with multiple sclerosis, this questionnaire was completed at baseline
and discharge physical therapy visits. This measure was also used to define the level of
disability for women with multiple sclerosis and to determine if a decline in function
occurred over the course of physical therapy management.
Based on previous behavioral training and physical therapy trials for women with
UI, it is estimated that 15%144, 182-18%16 will be treated < 2 visits or will not complete at
least one of the three initial primary outcome measures and 2%16 will report pain with
urination indicating possible infection. Thus, data from approximately 20% of women
managed by CRS PTs during the study period were expected to be excluded from
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consideration. Data from 166 women were expected to be reviewed with the expectation
that data from 138 women would eligible for study inclusion.

3.3 Procedures
3.3.1 Uniform Data Collection Procedures
Data were entered by the PT responsible for the patient’s care into an electronic
database designed for quality improvement and research purposes. The database was
developed based upon input from the CRS Director of Women’s Health Physical Therapy
at CRS, the CRS Chief Operating Officer, and the 15 CRS PTs who specialized in
women’s health physical therapy. The database had the capacity to store the following
data: patient demographics; medical, surgical (including obstetric and gynecologic) and
medication history; urinary symptoms; dietary intake (fiber, fluid, caffeine);
musculoskeletal and neuromuscular impairments identified during the physical therapy
examination; physical therapy interventions administered during the course of patient
care; barriers to intervention recommendations; and study outcome scores (PGI-I, PFDI20, PFIQ-7, CSS, FSFI).
To promote consistency and uniformity in data collection, the medical history
form completed by the patient at the initial physical therapy examination was developed
to parallel medical, surgical, and medication history database fields. Likewise, physical
therapy examination and intervention forms were developed to ensure uniform and
comprehensive documentation, adherence to CRS documentation standards, and
concurrence with examination and intervention database fields. In addition, one inperson meeting between the CRS Women’s Health PTs and the primary study

90

investigators occurred to discuss and operationally define the tests and measures utilized
during the physical therapy examination.
Finally, three in-person meetings were conducted between the CRS Women’s
Health PTs and the primary study investigators to discuss and educate the PTs on existing
valid and reliable pelvic-floor specific symptom and quality of life outcome measures.
Based on input from the PTs, outcome measures were selected to assess the impact of
physical therapy management on the patient’s global impression of improvement, pelvic
symptoms, and patient’s health-related quality of life. The PTs were educated on
procedures for administering and scoring these measures.

3.3.2 Selected Outcome measures/questionnaires
Study primary outcome measures included the PGI-I, PFDI-20, and PFIQ-7. Only
the PGI-I score obtained at the discharge examination was collected. The PFDI-20 and
PFIQ-7 questionnaires were completed by women at their initial (baseline) and discharge
physical therapy examinations.
The PGI-I is a global index to assess the patient’s perception of improvement
following treatment intervention.170-173 The PGI-I has been shown to have good construct
validity for treatment response in women with SUI.77 It includes one question that asks
the respondent to compare their current condition to how it was prior to starting
treatment. The response range is 1-7, with 1 being “very much better” and 7 being “very
much worse.” Thus, lower scores indicate an improvement in the condition, while higher
scores indicate a worsening of the condition.
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The PFDI-20 and PFIQ-7 are condition-specific instruments that assess urinary,
bowel, and prolapse symptoms, and the impact of urinary, bowel, and prolapse symptoms
on a woman’s quality of life, respectively. Because it is common for several pelvic floor
disorders to co-exist in the same woman,31 the use of instruments that assess the whole
spectrum of interrelated symptoms is essential when evaluating the efficacy of treatment
interventions. The PFDI-20 has a total of 20 questions and contains 3 subscales: the
Urinary Distress Inventory-6,183 the Pelvic Organ Prolapse Distress Inventory-6, and the
Colorectal-anal Distress Inventory-8. Respondents are asked to endorse the presence of
symptoms and the degree of bother on a scale from 1 (not at all) to 4 (quite a bit)
associated with each symptom. The 3 subscales of the PFDI-20 are scored from 0 (least
distress) to 100 (greatest distress), and the summary PFDI-20 score includes the sum of
the 3 scales and ranges from 0 to 300. The PFIQ-7 has 21 items and contains 3
subscales: the Urinary Impact Questionnaire-7,183 the Pelvic Organ Prolapse Impact
Questionnaire-7, and the Colorectal-anal Impact Questionnaire-7. On this questionnaire,
respondents are asked to rate the degree their bladder, prolapse, and/or bowel symptoms
affect their activities, relationships, and feelings on a scale from 0 (not at all) to 3 (quite a
bit). Each of the subscales are scored from 0 (symptoms do not impact) to 100 (symptoms
greatly impact) with an overall PFIQ-7 summary score ranging from 0 to 300. Both the
PFDI-20 and PFIQ-7 are valid, reliable, and responsive to change, and demonstrate
significant correlations with the long versions of the PFDI and PFIQ ( ICCs ranging from
0.86-0.93 and 0.94-0.96 respectively).78
Secondary study outcome measures included the CSS and FSFI. These
questionnaires were completed at initial (baseline) and at discharge physical therapy
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examinations. The CSS is a valid instrument that assesses the bowel habits and
symptoms of constipated patients.79 The CSS contains 7 items that are scored from 0-4.
A score of 0 indicates less distress and a score of 4 indicates greatest distress. An
additional CSS item queries the type of assistance needed to produce a bowel movement.
Score range on this item is from 0 (without assistance) to 2 (digital assistance or enema).
Thus, the total CSS score ranges from 0-30, with a score greater than 15 indicating
constipation. The brevity of CSS is advantageous. In addition, Agachan and colleagues
reported that the CSS demonstrated convergent and divergent validity as well as
significant correlation with anal and colorectal physiologic studies.79 However, the
reliability, responsiveness, and sensitivity to change of the CSS have not been
determined.
The FSFI is a 19-item questionnaire that measures sexual function across 6
domains: desire, arousal, lubrication, orgasm, satisfaction, and pain.80 An advantage of
the FSFI is that one domain, instead of the entire questionnaire, can be administered.
This study utilized only the pain domain which includes 3 questions. The questions query
how often the respondent experiences pain during vaginal penetration, after vaginal
penetration, and the degree of discomfort during or following penetration. FSFI items are
rated on a 5 point Likert-type scale with “1” indicating that the respondent “almost
always” has pain and “5” indicating she “almost never” has pain. The respondent is also
given the choice of “0” indicating “did not attempt intercourse” for each item yielding an
overall score range of 0-6. Consequently, higher scores on the FSFI indicate better
sexual function. The pain domain of the FSFI has high internal consistency (Cronbach’s
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alpha 0.92-0.94), moderately high test-retest reliability (r=0.69-0.87), and discriminant
validity.80

3.3.3 Selected Patient Demographic, History Data
Based on the pathophysiology and risk factors for UI, the history review for a
woman with UI should be multi-factorial taking into account the patient’s demographics;
gynecologic/obstetric history; comorbid conditions (including presence of co-existing
pelvic symptoms); medication use; dietary habits (fiber, fluid, and caffeine intake); and
current smoking status. Table 3.2 identifies selected patient demographic and history
information investigated for their possible impact on intervention outcomes. The table
also includes the rationale for inclusion into the database. In addition, the number of
physical therapy visits may also impact physical therapy outcomes. According to a
recent systematic review, treatment effect may be greater in women with SUI who
received a longer duration of PFM training (6 months versus 8 weeks).17 Subsequently,
the association between the number of physical therapy visits and outcomes was also
investigated. To describe the study sample, the following selected patient demographic
and history data were used: marital status (married/living as married or not married),
menopausal status (regular cycle, perimenopause, or menopause), medications (drug
therapy for UI, diuretics, hormone replacement, psychotropic medications, and/or
narcotics/analgesics), pelvic surgeries (hysterectomy, abdominal/ anal-rectal/bladder
surgery, and/or urethral dilation) types of urinary symptoms (difficulty emptying, urinary
frequency, urinary urgency, nocturia, SUI symptoms, and/or UUI symptoms), duration of
UI (years) and dietary habits including caffeine intake (< 2.5 cups per day or ≥ 2.5 cups
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per day), water (< 3 or 3-6 or >6 glasses per day) and fiber intake (do or do not include
fiber in diet). Both predictor variables and selected demographic/history data were
extracted from the patient’s medical record and entered into the database.
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Table 3.2: Components of the Demographic/History Review
Demographic Factors
Age (years)

Older age significant risk factor for UUI48, 50, 59 and increased
severity of symptoms47

Race/Ethnicity
(Caucasian or non-Caucasian)
Obstetric History

Caucasian significant risk for UI55

Parity (0,1,2,3,>3)

Possible injury to pudendal nerve, disruption of intravaginal
attachments of vagina, stretching and tearing of PFM9

Comorbidities that affect bladder function
Body Mass Index (kg/m2)

BMI > 30 significant risk for SUI50, 57 and increased severity of
symptoms48

Respiratory disease, chronic
coughing

Increase bladder volume and pressure184

Bowel dysfunction
Constipation
Irritable Bowel Syndrome
Fecal incontinence

Straining during defecation may lead to pudendal nerve injury46
Possibility of contributing to smooth muscle dysfunction65
Mechanical disruption of connective tissue, muscle or nerve injury
disrupt normal bladder support or function46

Neurological conditions
(Cerebrovascular accident,
Multiple sclerosis, Other)

Impair sensorimotor function and impair normal tonic inhibition of
parasympathetic pathway9, 184, 185

Diabetes

Impair sensorimotor function and impair normal tonic inhibition of
parasympathetic pathway9, 184, 185

Pelvic organ prolapse

Mechanical disruption of connective tissue, muscle or nerve injury
disrupt normal bladder support or function46

Pain
Pelvic pain

Urologic116-118 or musculoskeletal116-118 causes of pelvic pain may
directly impact bladder function

Low back pain

May disrupt PFM function via pain inhibition or decreased muscle
reaction67

Pelvic surgery

Cause possible tissue injury or impair neuromuscular function184

Dietary and Lifestyle Habits
Carbonated beverages
(> 1 per week or <1 per week)

Postulated that the ingredients in these beverages (sugar, artificial
sweeteners, citric acid) may irritate the bladder57

Smoking

Increase bladder volume and pressure184
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3.3.4 Tests and Measures
Data obtained from the patient during the initial and discharge physical therapy
examinations included the presence of pelvic organ prolapse, PFM strength, and PFM
tension/pain. The examination data were entered into the database and utilized to
describe the study sample.

3.3.4.1 Pelvic organ prolapse
To measure pelvic organ prolapse (POP) via vaginal palpation, patients were
positioned in hook-lying. The PT inserted two lubricated fingers to the level of the PIP
joint into the patient’s vagina.186 The examiner then pressed down on the patient’s
posterior vaginal wall to enhance visualization of the anterior vaginal wall. The patient
was then asked to bear down or cough. Bulging tissues on the anterior vaginal wall
indicate a prolapse of the bladder (cystocele), urethra, or cervix, which werwe
subsequently graded on a scale of 0-IV (Table 3.3). To examine the posterior vaginal
wall, the examiner separated the examining fingers laterally and pressed against the
posterior vaginal wall. The patient was then asked to bear down or cough. Bulging of the
posterior wall indicates a rectocele which was subsequently graded on the 0-IV scale.186
If the patient had multiple pelvic organ prolapse (i.e. rectocele and cystocele), the PT
entered the most severe prolapse grade into the database.
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Table 3.3: Pelvic Organ Prolapse Grades
Grade

Description

Grade 0

No prolapse is demonstrated

Grade I

Deep prolapse; palpable only

Grade II
Grade III

Prolapse half-way toward level of introitus; palpable and
visualized
Prolapse at level of introitus; visualized

Grade IV

Prolapse outside level of introitus; visualized

3.3.4.2 Pelvic Floor Muscle Strength
Several methods have been described to examine and evaluate pelvic floor muscle
(PFM) strength, including manual muscle testing via vaginal palpation and manometry.69
Correct contraction of the PFM includes both a squeeze around the pelvic openings and
an upward lift. Measures to examine and evaluate strength should take into account both
the squeeze and lift components. Most PTs utilize vaginal palpation and the modified
Oxford scale to evaluate PFM strength because squeeze pressure and lift are included in
the Oxford scale criteria.69
To measure PFM strength via vaginal palpation, patients were positioned in hooklying. The examiner inserted two lubricated fingers approximately 3.5 cm inward from
the patient’s vaginal introitus to palpate the levator ani. The patient was then asked to
“lift and squeeze” the PFM as tightly as possible around the examiner’s fingers. PFM
strength was graded based on the modified Oxford Scale as detailed in Table 3.4.187
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Table 3.4: Modified Oxford Scale for PFM Strength
Grade
0
1
2
3
4
5

Description
No movement palpable
Minimal or very small muscle bulging on palpation
Small range of motion, weak with brief hold
Definite muscle movement, upward lift to half range
Firm muscle movement closing around finger, upward lift to half to
three-quarter range
Very firm muscle pull that compresses finger, upward lift to full range
and strong hold
The modified Oxford scale has good intra-tester and inter-tester reliability.187, 188

Neumann investigated the intra- and inter-rater reliability of PTs performing the modified
Oxford scale in a multi-site study. For intra-rater reliability, Neumann found complete
agreement between test 1 and test 2 in 13 out of 14 tests, representing 93% overall
agreement and 100% agreement to within one grade (Kappa coefficient 0.9, p<0.001:
suggesting almost perfect agreement).187 Inter-tester reliability between 50 PTs at 6
different sites showed 56% inter-rater agreement (Kappa coefficient = 0.4, p<0.001),
suggesting fair agreement between the PTs and Neumann. In 42% of the tests, there was
a difference of one grade. Thus, there was 96% agreement within one grade between the
PTs and Neumann.187 Similarly, Bo and Finckenhagen reported acceptable inter-test
reliability (Kappa coefficient = 0.47) between PTs utilizing the modified Oxford scale.
In 9 of the 10 cases of disagreement, one PT consistently rated subjects one grade lower
than the other PT,188 indicating a systematic difference between the raters. It is
recognized that PFM testing via vaginal palpation may not provide the sensitivity and
responsiveness necessary for scientific investigations, while other measures may be more
appropriate in measuring force.69 However, vaginal examination and rating the PFM
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using the modified Oxford scale is a clinically accepted method by PTs for evaluating
PFM function.

3.3.4.3 PFM Tension and Pain
Muscle tension testing via palpation is a test performed by PTs to assess the
quality of the muscle.7 For example, if a muscle feels excessively “soft,” the PT may
suspect muscle atrophy. Conversely, if a muscle feels excessively “hard,” the PT may
suspect muscle spasm. There are no standard measures to evaluate muscle tension. Thus,
we operationally defined muscle tension for the purpose of evaluating pelvic floor muscle
tension. A grade of atrophy indicated low muscle bulk, a grade of normal indicated
normal muscle bulk, and a grade of spasm indicated tissue restriction to palpation or
stretch. In addition, pain noted upon palpation of muscle tension was rated by the patient
on a 0-10 scale (0 = no pain and 10 = worst imaginable pain).7

3.3.5 Intervention
3.3.5.1 Treatments Received
The PT evaluated data gathered from the initial examination and determined the
patient’s plan of care. The plan of care was individualized for each patient and included
standard physical therapy interventions. Standard physical therapy intervention for
pelvic floor dysfunction may consist of standard physical therapy interventions used to
treat other diagnoses.7 Such interventions include those to address pain (modalities),
improve strength and coordination of the PFM (PFM exercise with or without
biofeedback and/or electrical stimulation), improve strength of abdominal and/or lumbar
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extensor muscles, and improve range of motion (flexibility exercises, soft tissue/joint
mobilization). Patient education was also recorded including recommendations for
bladder and/or bowel training, fluid management, and diet modification. PTs entered
their interventions in their plan of care and in the database at the initial examination,
monthly following the initial examination, and at the time of discharge from physical
therapy. Intervention categories included in the database are outlined in Table 3.5.

101

Table 3.5: Intervention categories with evidence-based references of justification noted
Modalities

Manual physical therapy procedures

Heat130

Soft tissue mobilization to decrease soft tissue
restriction and improve range of motion125, 127

Ice130

Joint mobilization to improve range of
motion128

PFM Biofeedback18, 23-26, 76, 144, 145
 To promote strength and endurance
 To increase coordination
 To promote muscle relaxation
PFM Electrical Stimulation16, 26
 To improve PFM muscle strength (if
< 2/5 PFM strength)
 To promote sensory awareness due to
sensory impairment
 To reduce pain

Exercises

11, 13-18, 20, 22, 23, 68, 70, 141

PFM






Manual facilitation
Gravity eliminated
Anti-gravity
During functional tasks
Downtraining

Core Stabilization71, 72
 Transverse Abdominus
 Other Abdominal
 Multifidus
 Functional
Flexibility
 Hip130
 Lumbopelvic67, 130

Education

Body mechanics/posture117, 128, 132
Bladder/bowel schedule75
Diet modification
 Caffeine reduction56
 Carbonated beverage reduction56
 Increase water intake159
 Decrease water intake152, 153
 Fiber education159, 160
Relaxation techniques to decrease muscle
tension132, 165
SUI strategies22, 73 (PFM contraction before
increase in intra-abdominal pressure)
UUI strategies74-76 (inhibition techniques to
suppress bladder contractions)
Toilet strategies
 Constipation (toilet posture to
promote bowel movement)40, 189
 Voiding without straining
Soft tissue massage (abdominal massage,40
scar massage,130, 132 self-stretching for
introitus127)
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3.3.5.2 Barriers to Intervention Recommendations and Changes in Intervention
If a patient was not progressing with the plan of care, the PT recorded changes in
the plan of care and barriers impacting outcomes during monthly re-evaluation visits. The
presence or absence of barriers to intervention recommendation was utilized as a
predictor variable for statistical analysis. The changes in plan of care were reported
descriptively for the entire study sample. Table 3.6 defines the categories utilized in the
database.
Table 3.6: Barriers to Intervention Recommendations and Changes in Plan of Care
Barriers to Intervention Recommendations




Patient did not attend all recommended physical therapy visits
Patient was not adherent to home exercise program
Patient did not adhere to recommended lifestyle modifications (fluid management, diet
modification, urge/stress, strategy, etc)
 Cognitive impairments interfered with patient’s ability to follow through with physical
therapy recommendations
 Comorbidities contributed to UI or interfered with the patient’s ability to follow the
plan of care
 Medications contributed to UI, limiting outcomes
 Sensory loss limited patient’s ability to recognize correct muscle contraction
 Profound muscle weakness/muscle denervation limited potential for increased muscle
function
Changes in plan of care due to barriers encountered during physical therapy sessions







Patient education on importance of visit attendance
Change in exercise intensity (increased intensity to promote strength, decreased
intensity due to lack of patient adherence to home exercise program)
Internal PFM facilitation due to lack of ability to contract PFM
Functional PFM activation (progression of PFM exercise in standing postures)
Further interdisciplinary or specialist consultation
Increase in core (abdominal, lumbar extensor) exercises to promote PFM recruitment

3.4 Statistical Analysis
Statistical analysis was completed using a commercially available software
package (SPSS; Chicago, IL). Descriptive statistics were calculated to describe the
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selected demographic and history information, examination findings, and to describe
primary (PGI-I, PFDI-20, PFIQ-7) and secondary (CSS, FSFI) outcome scores of women
with UI following pragmatic physical therapy management. Demographic sample
characteristics included: age, race/ethnicity, body mass index, and marital status. History
sample characteristics included: parity; number of comorbidities; pelvic surgeries;
menopausal status; medications; types of urinary symptoms; duration of UI; smoking
status; and dietary habits including caffeine, carbonated beverage, water, and fiber intake.
Examination findings described for the study sample included pelvic organ prolapse
grade, PFM strength grade, and PFM tension/pain.
To determine if pelvic symptoms (PFDI-20) or health-related quality of life
(PFIQ-7) was altered by physical therapy interventions, mean baseline and postintervention scores for each dependent variable were compared with a paired t-test. To
determine if constipation symptoms (CSS) or pain with sexual intercourse (FSFI) was
altered by physical therapy interventions, mean rank baseline and post-intervention
scores for each dependent variable were compared with a Wilcoxon signed-rank test. To
determine women’s perception of improvement attributed to physical therapy
interventions, the median post intervention PGI-I score was reported. No pre-post
intervention on this outcome was performed as this measure was obtained only at
discharge from physical therapy.
Correlation coefficients were calculated to determine if age, number of physical
therapy visits, and number of comorbidities were related to PFDI-20 and PFIQ-7
outcomes. Correlations between PFDI-20 change scores (PFDI-20 postintervention –
PFDI-7 baseline) and age (years) and number of physical therapy visits were
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independently assessed using Pearson correlation coefficients. Correlations between
PFDI-20 change scores and number of comorbidities were assessed using Spearman’s
rho. In a similar fashion, PFIQ-7 change scores were assessed. Variables with
correlations with a p-value of < 0.10 were entered into a stepwise linear regression.
To examine the relationship between PFDI-20 change scores and the dichotomous
independent variables of parity (nulliparous or parous), presence of barriers to
intervention recommendations (none or ≥1), race, (Caucasian or non-Caucasian),
carbonated beverage intake (≥1 per week or <1 per week), and current smoking status
(smoker or non-smoker) a stepwise linear regression was used. To determine the
dichotomous variables to be included in the stepwise linear regression, the mean PFDI-20
change scores associated with both categories of a dichotomous variable were calculated
and compared using a two sample t-test. For example, the mean PFDI-20 change score
for Caucasian subjects was compared to that of non-Caucasian subjects. Should a
significant difference in mean score (p < 0.10) exist between the two categories of a
dichotomous variable; the dichotomous variable was included in the stepwise linear
regression. The same procedure was used to examine the relationship between PFIQ-7
change scores and dichotomous variables.
Two sample t-tests and chi-square analysis were used to determine if predictor
variables were related to treatment success or failure. For these analyses, post
intervention PGI-I scores were divided into 2 categories: scores indicating treatment
success and scores indicating treatment failure. Treatment success was defined by a postintervention PGI-I score of “much better” or “very much better” while treatment failure
was defined by the PGI-I scores of “a little better,” “no change,” “a little worse,” “much
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worse,” and “very much worse.” Two sample t-tests were used to compare the mean age,
number of comorbidities, and number of physical therapy visits between success and
failure groups. Variables showing statistically significant differences between groups (pvalue ≤0.10) were entered into a stepwise logistic regression. Finally, chi square analyses
were utilized to determine if parity (nulliparous or parous), presence of barriers to
intervention recommendations (none or ≥1), race (Caucasian or non-Caucasian),
carbonated beverage intake (> 1 per week or <1 per week), and current smoking status
(smoker or non-smoker) significantly influenced the distribution of women to the
categories of success and failure. Variables resulting in a p-value of < 0.10 were entered
into a stepwise logistic regression.
Descriptive statistics were utilized to address the secondary aim of describing the
types of interventions received by women. For these analyses, data from women were
presented according to symptom constellation (UI symptoms only, UI + bowel
symptoms, UI + pelvic pain, or UI + bowel symptoms + pelvic pain). However, for
selected interventions, the proportion of women receiving the intervention was
presented for specific subgroups. For example, education on the stress strategy was only
applicable to women with SUI symptoms. Thus, the percentage of women who received
education on the stress strategy was documented for women with SUI symptoms only.

3.5 Power Analysis
The minimum important difference (MID) is the smallest change in score
associated with a clinically meaningful change in a questionnaire.81 Statistical tests are
not responsive to practical or clinical implications of the data. Subsequently, statistical
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differences may not be clinically meaningful changes and determining the MID is
essential in interpreting questionnaire results. To date, there have been no trials
investigating the impact of physical therapy interventions on concurrent urinary, bowel,
pelvic organ prolapse, and sexual function symptoms in women utilizing the PFDI-20
and PFIQ-7. However, Barber and colleagues estimated the MID for the urinary
subscales in the PFDI and PFIQ long questionnaires.190 Women with SUI were
randomized into 1 of 3 interventions: an incontinence pessary, a 12-week behavioral
therapy program, or both. The behavioral program consisted of 4 clinic visits at 2-week
intervals and included PFM exercise and education in SUI strategies. Using both anchorand distribution-based approaches to calculate the MID, Barber evaluated the change in
score from baseline to 3 months after initiating treatment. Anchors used were the PGI-I,
incontinence episodes from a urinary diary, and the Incontinence Severity Index. The
MID for the urinary subscales of the PFDI and PFIQ were 11.1 and 16.0 respectively.190
Essentially, a change score of 11 on the PFDI urinary subscale differentiated those who
were “about the same” from those who were “better.” Although this study utilized the
long forms of the PFDI and PFIQ, the short forms (PFDI-20 and PFDI-7) have been
shown to be significantly correlated with the long forms with ICC values between 0.70
and 0.91.78 Using a 99% CI, a MID of 11, and standard deviations from Barber’s trial, an
initial sample size of 138 patients was determined based on the formula below. Taking
into account that 20% of the available medical records will meet exclusion criteria, the
sample size appropriate for this study is 166.
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PFDI-20
((2.58*standard deviation) / MID))=n2
((2.58*32)/11)2=56
Based on the proportions reported in Barber, we would expect that approximately 10% of
women would get worse (overestimate) [n=6], 10% would stay about the same [n=6],
30% would get better [n=57], and 50% would get much better [n=69] for a total of 138
patients.
Although an initial sample size of 166 was calculated to determine efficacy of
physical therapy treatment on the PFDI-20 and PFIQ-7 scores, a second power
calculation was performed to determine the number of subjects necessary to perform the
stepwise linear regression analysis using the 2-step rule-of-thumb based on Cohen’s
power analytic approach. The calculations utilize a power of 0.80, alpha of 0.05, and an
effect size (f2) for regression analysis of 0.15 which indicates a medium effect size based
on Cohen’s work.191
Step 1: Compute lambda (L): L = 6.4 + 1.65m – 0.05m2 where m equals the number of
independent variables.
Step 1 results: L = 6.4 + 1.65(8) + 0.05(82) = 16.4
Step 2: Compute required minimum sample size: N = L / f2
Step 2 results: N = 16.4 / 0.15 = 109.3 = 110
Since 138 > 110, the most appropriate sample calculation for this study was 166 taking
into account that 20% of the medical records will meet exclusion criteria.
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Chapter 4
Results
4.1 Subjects
Between November 1, 2009 and November 15, 2010, 500 physical therapy
records were screened by the CRS honest broker. Data from 100 women met study
inclusion criteria, were extracted from the database, and included for data analysis.
Ninety eight percent of the participants were Caucasian and their mean age was
54.4 ± 15.2 years. Most women (82%) were parous, 16% were nulliparous, and 2% did
not report parity. Median parity of the sample was 2.0 (1st quartile value = 1.0 and 3rd
quartile value = 3.0). Body mass index was reported for 70/100 subjects (mean 27.9
kg/m2± 7.1). Only one participant (1%) reported smoking. Participants reported a
variety of urinary symptoms, with most women (49%) reporting more than one urinary
symptom. Most of the women in the study complained of SUI (54%), while 37%
described urgency symptoms and 35% noted UUI. The mean duration of UI and the
mean number of physical therapy visits attended for all women in the study was 5.4 ± 7.0
years and 7.9 ± 4.9 visits, respectively. The remaining participant characteristics are
presented in Table 4.1. Table 4.2 summarizes the participants’ history of pelvic surgeries
and comorbid conditions and the use of medications that are known to impact bladder
function. The most commonly reported comorbidities were pelvic pain, constipation,
irritable bowel syndrome, and low back pain. Forty-three percent of women were taking
medications known to impact urinary continence.
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Table 4.1: Characteristics of participants
Characteristic (n=100)

Values (n)

Age (years), mean (SD)
Race/Ethnicity
Caucasian
Non-Caucasian
Parity
Nulliparous
Parous
Unreported
Marital Status
Married, living as married
Separated, divorced, widowed, single, or never married
Menopausal status
Regular cycle
Irregular cycle
Peri-menopause
Menopause
Unreported
Types of Urinary Symptoms
Difficulty emptying
Frequency
Urgency
Nocturia
Stress urinary incontinence
Urge urinary incontinence
Number of physical therapy visits attended, mean (SD)
Body mass index (kg/m2), mean (SD) (n=70)

54.4 (15.2)
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98
2
16
82
2
75
25
27
4
4
63
2
13
35
37
15
54
35
7.9 (4.9)
25.9 (7.1)

Table 4.2: Medical history / medications of participants
Characteristic (n=100)
Pelvic Surgeries
Hysterectomy
Abdominal surgery
Anal/rectal surgery
Bladder surgery
Urethral dilation
None
Comorbidities
Lung disease
Diabetes
Irritable bowel syndrome
Constipation
Fecal incontinence
Stroke
Multiple sclerosis
Other neurological
Frequent UTI (> 3 per year)
Abdominal pain
Low back pain
Pelvic pain
Medications that impact urinary continence
Drug therapy for urinary incontinence
Diuretics
Hormone replacement
Psychotropic
Narcotics / Analgesics
None

Values (n)
26
23
11
15
4
21
3
4
30
38
12
4
1
4
6
17
27
45
8
3
7
11
14
57

Table 4.3 summarizes selected physical therapy examination findings including
presence of pelvic organ prolapse and PFM tension/pain; and reported dietary habits.
Less than half of the women (43%) presented with pelvic organ prolapse. Most women
(78%) demonstrated abnormal pelvic floor muscle tension /pain upon vaginal palpation.
Most participants reported intake of < 1 carbonated beverage/wk and ≤ 2.5 cups of
caffeine per day. Forty-three percent of women were drinking fewer than 3 glasses of
water per day. Less than half of women included fiber in their daily diet. In addition, the
sample median Oxford muscle strength grade was 2, indicating the levator ani contraction
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was weak and brief; and that the contraction resulted in a small range of pelvic floor
motion.
Table 4.3: Examination findings of participants
Characteristic (n=100)
Pelvic organ prolapse
Grade 0
Grade I
Grade II
Grade III
Grade IV
Unreported
PFM tension/pain
Normal
Abnormal
Atrophy
Spasm
Pain upon vaginal palpation
Dietary Habits
Caffeine intake ≥2.5 cups per day
Caffeine intake < 2.5 cups per day
Carbonated beverage intake ≥ 1 beverage per week
Carbonated beverage intake < 1 beverage per week
Fiber included in diet
Fiber not included in diet
Water intake
<3 glasses per day
3-6 glasses per day
>6 glasses per day
Unreported

Values (n)
53
17
18
4
1
7
22
78
32
56
59
27
73
16
84
43
57
43
43
9
5

4.2 Physical Therapy Outcomes
Fifty-four and 52 participants completed the initial and discharge PFDI-20 and
PFIQ-7 questionnaires, respectively. In addition, 3 women did not complete either
questionnaire at initial or discharge evaluations. All participants reported a PGI-I score
post-intervention. Secondary outcomes including the CSS and FSFI were not
administered routinely to study participants with only 10 participants and 5 participants
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completing the CSS and FSFI, respectively. Consequently, CSS and FSFI scores were
excluded from statistical analysis.
Baseline, post-intervention, and baseline-post-intervention change scores for the
PFDI-20, PFIQ-7; and the distribution of post-intervention PGI-I scores are presented in
Table 4.4. Baseline to post-intervention PFDI-20 and PFIQ-7 scores were significantly
reduced (p<0.001) indicating that women’s pelvic symptoms and health-related quality of
life improved following physical therapy intervention. The median value in the PGI-I
frequency distribution was “2” indicating that women perceived their symptoms as
“much better” following physical therapy. Sixty-six percent of women achieved the study
criteria for PGI-I treatment success, with 28 women reporting a PGI-I score of “1”
(symptoms are “very much better”) and 38 women reporting a PGI-I score of “2”
(symptoms are “much better”).
Because only about half of the sample completed the PFDI-20 and PFIQ-7 at
discharge, results of an intention-to-treat analysis (n= 97) are presented. For these
analyses, the initial PFDI-20 and PFIQ-7 scores were carried forward when the discharge
outcome scores were missing. This intention-to-treat analysis supported the efficacy
analysis that showed that both PFDI-20 and PFIQ-7 scores significantly improved
following physical therapy intervention (p<0.001). The results of the intention-to-treat
analysis may be found in Appendix Table A1.1.
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Table 4.4: Outcome scores of study participants

PFDI-20
(n=54)
PFIQ-7
(n=52)

Mean
Baseline
Value
(±SD)

Mean Postintervention
Value
(±SD)

88.69±49.19

50.80±46.25

Baseline to
postintervention
change score
(±SD)
37.89±48.97

52.21±56.50

21.96±34.96

30.25±51.21

95% CI

tstatistic

p-value

24.5251.25
15.9944.51

5.686

<0.001

4.260

<0.001

NA

NA

NA

Frequency
Count
PGI-I Score
(n=100)
1=very much
better
2=much
better
3=a little
better
4=no
change
5=a little
worse
6=much
worse
7=very much
worse

NA

NA
28
38
26
7
1
0
0

4.3 Factors associated with Physical Therapy Outcomes
Mean PFDI-20 and PFIQ-7 pre- to post-intervention change scores did not differ
between women based on parity, presence of barriers to intervention recommendations,
or carbonated beverage intake (p>0.10). In addition, age, the number of physical therapy
visits, and the number of comorbidities were not statistically associated with PFDI-20 or
PFIQ-7 scores (p >0.10). (See Appendix A1.2 and A1.3 for tables.)
Age and number of physical therapy visits differed between women who did and
did not achieve PGI-I defined treatment success. Women who achieved treatment
success had a lower mean age (51.86±15.59 vs. 59.29±13.15 years, p<0.019) and had
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more physical therapy visits (9.05±5.51 vs. 5.74±2.55 visits, p<0.001) than those who did
not perceive symptom improvement. (See Appendix A1.4 for table.) There was no
difference in the mean number of comorbidities between women who perceived and did
not perceive treatment success.
The distribution of the occurrence of barriers between women who did and did
not perceive treatment success was different than would be expected by chance (Fisher’s
exact test p-value<0.001; Table 4.5). Specifically, 56% of women perceiving treatment
success reported no barriers to intervention recommendations and only 10% of women
perceiving treatment failure reported no barriers to intervention. The distribution of the
occurrence of parity and carbonated beverage intake was not significantly different
between women perceiving and not perceiving treatment success. (See Appendix A1.5
for tables.)
Table 4.5: Distribution of the occurrence of barriers when women are divided by PGI-I
success/failure
PGI-I Success
No barriers
56 (56%)
Presence of barriers
10 (10%)
Total
66 (66%)
Fisher’s exact test p-value<0.001

PGI-I Failure

Total

13 (13%)
21 (21%)
34 (34%)

69 (69%)
31 (31%)
100 (100%)

When age, presence of barriers to intervention recommendations, and number of
physical therapy visits were entered into the logistic regression model, only barriers to
intervention recommendations (p<0.001) and number of physical therapy visits (p=0.007)
were influential in predicting PGI-I outcome (Table 4.6). The odds of success for women
who did not report barriers to intervention recommendations were 12.8 times greater than
those for women who reported barriers to intervention recommendations (OR 12.82; 95%
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CI 4.05-40.55). In addition, as the number of physical therapy visits increased, a woman
was more likely to attain treatment success. Specifically, for each additional treatment
visit received, the odds for a woman to achieve treatment success increased 1.26 times
(OR 1.26; 95% CI 1.07-1.50).
Table 4.6: PGI-I success logistic regression model
Predictor
Constant
Age in years
Presence of barriers
Number of PT visits

Regression
Coefficient
-1.105
- 0.028
2.551
0.233

Standard Error

p-value

1.362
0.019
0.587
0.086

0.151
0.000
0.007

*The overall accuracy of predicting success is 80% based on this logistic regression
model.

4.4 Treatments Received
4.4.1 Education
94% of women in this study received some type of patient education (see Table
4.7). Education in body mechanics, relaxation techniques to decrease muscle tension,
and voiding without straining were most often prescribed for women with pelvic pain.
Education in soft tissue massage was provided most often to women who reported all 3
types of pelvic symptoms, urinary, bowel and pelvic pain. Alternately, therapists
provided education in bowel/bladder scheduling less often to women with concomitant
urinary, bowel and pelvic pain symptoms.
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Table 4.7: Education by category

Categories
UI only
UI + bowel
UI + pelvic pain
UI + bowel +
pelvic pain

n
10
31
5
54

Body
mechanics
n (%)
2 (20)
2 (6.5)
2 (40)
19 (35)

Bladder/
bowel schedule
n (%)
2 (20)
10 (32.2)
2 (40)
7 (13)

Relaxation
n (%)
1 (10)
3 (9.6)
3 (60)
37 (68.5)

Soft tissue
massage
n (%)
2 (20)
2 (6.5)
1 (20)
33 (61)

Void without
strain
n (%)
2 (20)
6 (19.4)
2 (40)
30 (55)

Fifty four women had SUI symptoms, 35 had UUI symptoms, and 38 women had
symptoms of constipation. Education in strategies to prevent UI episodes (stress strategy
for SUI and urge suppression strategy for UUI) was provided to 51.9% and 71.4% of the
women with SUI and UUI, respectively. For women with constipation, 71.1% were
educated in toileting strategies to promote bowel emptying.
Physical therapists educated 92.6% (25/27) of the women who indicated that they
consumed excessive caffeine to reduce caffeine intake; and 50% (8/16) of the women
who drank at least one carbonated beverage per week to reduce carbonated beverage
intake. Seventy-two percent of women (31/43) who consumed <3 glasses of water per
day received education on increasing water intake; and none of the 9 women drinking >6
glasses of water per day received education on decreasing water intake. In addition,
education to increase fiber intake was provided to 26/38 (68.4%) of the women with
symptoms of constipation.

4.4.2 Exercise
PFM training was included in the physical therapy plan of care for 98% of women
(Table 4.8). Downtraining was most often prescribed for women with pelvic pain
symptoms. Manual facilitation of the levator ani was included in the plan of care for 61%
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of the women. Gravity-eliminated PFM exercise was prescribed for 52% of women.
Finally, 75% of women performed PFM exercises in antigravity positions. In addition to
PFM training, ≥50% of women in each symptom category received core stabilization
training. Interestingly, women who received core stabilization training were significantly
more likely to obtain treatment PGI-defined success (Fisher’s exact test p-value=0.031)
than women who did not perform core stabilization exercises (see Table 4.9). Flexibility
exercises of the lumbar spine and hip were incorporated into the treatment plans of 20
women with UI + bowel + pelvic pain (37%) and 1 woman with UI only (10%). Women
in the other categories did not perform flexibility exercises.
Table 4.8: Exercise by category

Categories
UI only
UI + bowel
UI + pelvic pain
UI + bowel +
pelvic pain

n
10
31
5
54

PFM manual
facilitation
n (%)
4 (40)
21 (67.7)
2 (40)
34 (63)

PFM gravity
eliminated
n (%)
3 (30)
18 (58)
3 (60)
28 (52)

PFM antigravity
n (%)
9 (90)
28 (90)
1 (10)
37 (68.5)

PFM
downtraining
n (%)
1 (10)
4 (12.9)
4 (80)
43 (79.6)

Core
stability
n (%)
5 (50)
19 (61.3)
3 (60)
33 (61.1)

Table 4.9: Performance of Core stabilization exercise and Treatment Success on PGI-I

Women who performed core
stabilization
Women who did not perform
core stabilization
Total

Treatment Success
on PGI-I
45 (45%)

Treatment Failure
on PGI-I
15 (15%)

60 (60%)

21 (21%)

19 (19%)

40 (40%)

66 (66%)

34 (34%)

100 (100%)

*Fisher’s exact test p-value=0.031
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Total

4.4.3 Modalities
Physical therapists included modalities of hot/cold, biofeedback, and/or electrical
stimulation in the plan of care for 42% of women (Table 4.10). Only women with all
three pelvic symptoms received hot/cold modalities as part of their physical therapy
intervention. 17% of the total sample of women received biofeedback, while 22%
received electrical stimulation.
Table 4.10: Modalities and Manual Physical Therapy Procedures by category
Hot /cold
Categories
UI only
UI + bowel
UI + pelvic pain
UI + bowel +
pelvic pain

n
10
31
5
54

n (%)
0 (0)
0 (0)
0 (0)
14 (25.9)

Biofeedback
n (%)
5 (50)
7 (22.6)
1 (20)
4 (7.4)

Electrical
Stimulation
n (%)
2 (20)
11 (35.5)
2 (40)
7 (13)

Joint
mobilization
n (%)
0 (0)
1 (3.2)
0 (0)
16 (29.6)

Soft tissue
mobilization
n (%)
2 (20)
7 (22.6)
3 (60)
46 (85.1)

4.4.4 Manual physical therapy procedures
72% of the sample received some type of manual physical therapy procedures
(Table 4.10). Joint mobilization was predominantly prescribed for women with all 3
pelvic symptoms. Physical therapists performed soft tissue mobilization most often on
women with pelvic pain.

4.4.5 Barriers to intervention recommendations and changes in intervention
Thirty one women in the study reported barriers to intervention recommendations.
71% (22/31) of the women reported 1 barrier, 22.6% (7/31) reported 2 barriers, and 6.5%
(2/31) reported 3 barriers. The most common barriers noted were that the patient failed
to attend all recommended physical therapy visits, that patient’s comorbidities
contributed to UI or interfered with the patient’s ability to follow the plan of care, and the
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patient did not adhere to the home exercise program (Table 4.11). In response to these
barriers, physical therapists altered the plan of care of 87.1% (27/31) of the women. The
most common change in treatment plan was a change in exercise intensity (Table 4.11).
Functional PFM activation and introduction of core exercises to promote PFM
recruitment were the most frequently endorsed changes in exercise recommendations.
Table 4.11: Barriers to Intervention Recommendations and Changes in Plan of Care
Barrier to intervention recommendations (n=31)

n (%)

Patient did not attend all recommended physical therapy visits

10 (32.3)

Patient was not adherent to home exercise program

8 (25.8)

Patient did not adhere to recommended lifestyle modifications (fluid management,
diet modification, urge/stress, strategy, etc)

6 (19.4)

Comorbidities contributed to UI or interfered with the patient’s ability to follow
the plan of care

10 (32.3)

Medications contributed to UI, limiting outcomes

2 (6.5)

Sensory loss limited patient’s ability to recognize correct muscle contraction

1 (3.2)

Profound muscle weakness/muscle denervation limited potential for increased
muscle function
Changes in plan of care due to barriers encountered during physical therapy
sessions

5 (16.1)

Patient education on importance of visit attendance

10 (32.2)

Change in exercise intensity (increased intensity to promote strength, decreased
intensity due to lack of patient adherence to home exercise program)

21 (67.7)

Internal PFM facilitation due to lack of ability to contract PFM
Functional PFM activation (progression of PFM exercise in standing postures)
Further interdisciplinary or specialist consultation
Increase in core (abdominal, lumbar extensor) exercises to promote PFM
recruitment

5 (16.1)
13 (41.9)
1 (3.2)
11 (35.5)
13 (41.9)

Other
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Chapter 5
Discussion
5.1 Patient Characteristics
Similar to other reports, this investigation found that women with UI seeking
physical therapy services often complain of additional pelvic symptoms. Of the 100
community dwelling women seeking physical therapy for UI, nearly half (48%) reported
other co-existing pelvic symptoms as indicated by their responses to the Colorectal-Anal
and Pelvic Organ Prolapse subscale items of the PFDI-20. Co-existing bowel conditions
reported by women included constipation (38%), irritable bowel syndrome (30%), and/or
fecal incontinence (12%). The prevalence rates of bowel conditions in women with UI in
the present study are similar to rates previously reported. Specifically, previous
investigators have found the prevalence of constipation ranges from 3134-36%33; and the
presence of fecal incontinence in women with UUI to be 18% (mean age = 57).64 The
prevalence of irritable bowel syndrome in women with urinary symptoms has not been
previously reported. The current study also found that more than half of the women
(59%) reported PFM pain upon palpation. Questionnaires that address the whole
spectrum of pelvic symptoms are prudent in understanding the various impairments
women may possess when seeking physical therapy for UI.

5.2 Physical therapy outcome measures
This study found that physical therapy interventions provided within a pragmatic
setting are effective in improving pelvic symptoms, including urinary, bowel, and
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prolapse symptoms. It is well established that physical therapy interventions aimed
toward improving urinary symptoms are effective.11, 12, 14-18, 24, 70, 76, 108, 141, 143, 144, 182, 192-195
However, there are too few published data to conclude whether or not these physical
therapy interventions can effectively manage women with urinary and concurrent bowel
and/or pelvic organ prolapse symptoms. Even data to describe the types of interventions
used by physical therapists to manage women with a myriad of pelvic symptoms are
scarce. This study was unique in that it obtained data that described current physical
therapy practice from a large group (15) of physical therapists within one outpatient
physical therapy company (Centers for Rehab Services). It was not an aim of this study to
discern which intervention(s) were most successful. Thus, study conclusions are limited
toward the overall effectiveness of the physical therapy plan of care to reduce women’s
pelvic symptoms. Within this sample of convenience, this study found evidence that
Centers for Rehab Services physical therapists were very effective in reducing their
client’s pelvic symptoms.
Pre- to post intervention PFDI-20 and PFIQ-7 scores improved significantly by
37.89 and 30.25, respectively. Such statistical improvements exceed the minimum
important difference for both the PFDI-20 and PFIQ-7. Barber et al. reported minimum
important differences of 11.1 and 16.0 points for the urinary subscales of the PFDI and
PFIQ, respectively.190 Thus, women in the current study experienced a clinically
significant improvement in their symptoms. This conclusion is further validated by the
fact that 66% of women achieved at least or greater than a PGI-I score of 2, indicating
that symptoms were “much better”.
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A major limitation of the study is the small sample size. In order to determine
statistical difference in the baseline to post-intervention PFDI-20 and PFIQ-7 scores, the
power analysis revealed a sample size of 138. Although we had a large pool of medical
records in the database (500), only 100 subjects met the inclusion criteria. Of these 100
subjects, just over half of the patients completed both baseline and post-intervention
PFDI-20 (54 patients) and PFIQ-7 (52 patients) questionnaires. When smaller sample
sizes are used, true statistical differences are less likely to be recognized.167 Even with
this smaller sample size, we were able to detect a true difference between baseline and
post-treatment PFDI-20 and PFIQ-7 scores. The differences also exceeded the minimum
important difference as reported by Barber.190 Because women who did not complete the
questionnaires at discharge may have had poorer outcomes, intention-to-treat analyses
including these women were performed. The results of the intention to treat analyses
were congruent with the results of the efficacy analyses. That is both PFDI-20 and PFIQ7 scores significantly improved following physical therapy intervention.
We chose a global impression of improvement as a primary outcome measure in
order to obtain a very simple and direct appraisal of the patient perception of
improvement. The PGI-I is a global index used in recent research trials to assess patient
perception of treatment intervention.170-173 The PGI-I has been shown to have good
construct validity.77 Sixty-six percent of the women in our study achieved treatment
success as defined by the PGI-I. This is a slightly higher success rate than reported by
Richter et al. who also used the PGI-I. Richter et al. reported a per-protocol success rate
of 61.6% and an intention-to treat success rate of 49% for women who received physical
therapy management for SUI.182 In Richter’s study, treatment consisted of interventions
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aimed only at UI (PFM exercise and additional skills and strategies for active use of
muscles to prevent SUI and UUI).182 The present study included additional interventions
that may have contributed to the higher percentage of women attaining success. Our 66%
success rate is similar to the 60%-85% range for reduction in incontinence episodes
reported in other behavioral intervention trials.11, 16, 17, 24, 70, 141, 196, 197

5.3 Factors associated with Physical Therapy Outcomes
This study explored a number of variables that were thought to have potential for
influencing physical therapy outcomes. Regression analysis revealed that only two
variables influenced treatment success as defined by the PGI-I score. Patients without
barriers to intervention recommendations and patients who attended more physical
therapy visits were more likely to attain PGI-I defined success.
An absence of barriers to intervention recommendations was a strong predictor of
patient defined success. The odds of success for women who did not report barriers were
12.8 times greater than those for women who reported barriers. Our finding is similar to
Grindley et al. who reported a negative correlation between the total number of barriers
and treatment efficacy (r=-0.380) for patients of various diagnoses receiving outpatient
physical therapy for 4-8 weeks.198 In addition, Borello-France et al. reported that the
total number of barriers was significantly associated with a lower number of PFM
exercises performed by women with predominant UUI (p<0.05).199 One of the most
common barriers in the present study was non-adherence to the prescribed home exercise
program. Eight percent of all women in the study (8/100) reported not adhering to the
home exercise program during the intervention period. This rate is similar to non-
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adherence rates (7%-13%)11, 199 to behavioral therapy previously reported. Additionally,
patient non-attendance was another common barrier. It is generally believed that the
failure of a patient to attend therapy sessions can interfere with rehabilitation process and
potentially impact outcomes. In our study, 10% of the women did not attend physical
therapy regularly which may have impacted their outcomes. Forkan et al. reported that
barriers, and not motivators, predicted adherence to physical therapists’ recommendations
following discharge.200 The evidence from this and other cited studies strongly support
the need for physical therapists to engage their patients in order to identify and resolve
barriers to intervention recommendations.
The number of physical therapy visits received was associated with PGI-I defined
treatment success. The odds of success for a woman receiving one additional physical
therapy visit increased 1.26 times. This finding confirms that of Hay-Smith who reported
treatment effect may be greater in women with SUI who receive a longer duration of
PFM training (6 months versus 8 weeks).17 Yet, research investigating a relationship
between number of physical therapy visits and treatment outcome is lacking. Trials
exploring predictors of physical therapy outcomes routinely have little variability in the
number of physical therapy visits administered.13, 201-203 The pragmatic design of the
present study captured a large variance of physical therapy visits (2-29 visits) and
subsequently, statistical analysis was possible.
Most of study variables identified as possible predictors of outcomes were not
confirmed statistically as such. Parity which is a known risk factor for UI48, 51-54 was
unrelated to physical therapy outcomes. Our finding is similar to Theofrastous et al. who
found no relationship between parity and reduction of incontinent episodes per week in
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community-dwelling women (mean age 60.6±10 years) with SUI, UUI, or mixed
incontinence following treatment that included biofeedback-assisted pelvic floor muscle
exercise training or bladder training.203 Similarly, Burgio et al. reported no relationship
between parity and reduction of incontinent episodes in ambulatory, community-dwelling
women with UI that were managed with behavioral treatment.13, 204 Burgio’s conclusion
was based on pooled data from 3 prospective randomized clinical trials that tested
behavioral therapy (PFM exercise, stress/urge strategies, and self-monitoring with
bladder diaries) in women with UUI, urge-predominant mixed incontinence, or SUI.13
Although comorbidities may influence the complexity of the intervention,7 they
did not relate to treatment outcomes in this study. This finding is similar to those of
McDowell et al205 and Burgio et al.13 McDowell reported no relationship between the
number of medical diagnoses and degree of improvement in incontinent episodes per
week in persons with UI and multiple comorbidities (mean 6.0 problems) receiving
behavioral intervention (PFM exercise and stress/urge suppression strategies).205
Similarly, Burgio reported that treatment outcomes did not associate with medical history
(including arthritis, bladder infections, constipation, age at menopause, duration of
menopause, hysterectomy, and use of alcohol).13 The influence of comorbidities may
have been minimized in our study due to the selection and categorization procedure used.
For example, the comorbidities selected for exploration in our study included only those
identified as documented risk factors for UI (body mass index >30, lung disease,
diabetes, bowel/constipation/irritable bowel syndrome/fecal incontinence, neurological
diseases, pain [lumbar or pelvic pain], pelvic surgery [hysterectomy, abdominal, rectal,
bladder, urethral dilation], and pelvic organ prolapse). Yet, results of the present study,
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along with results of previous investigations,13, 205 suggest that the complexity of a
woman’s medical history does not relate to treatment outcomes. Consequently, a woman
may be able to respond favorably to physical therapy interventions despite a complex
medical history.
In univariate analysis, women who achieved treatment success had a lower mean
age than those who did not perceive symptom improvement. Previous investigations
have found that age was not related to reduction of incontinence.35, 38, 46-50 However,
unlike studies that explored age within a restricted range (minimum 40 to maximum 97
years),35, 38, 46-50 the age range of women in our study was not restricted (minimum 20 to
89 yrs) which may have contributed to our significant findings. The only other trial with
a similar age range (range 25 to 81 years, mean age 54 years), conducted by Smith et al,
found a significant difference in improvement noted on bladder diaries between those
<40 years and those >60 years of age. Younger women reported more improvement than
older women with SUI, UUI, and mixed UI in episodes of incontinence per day following
behavioral therapy.51
Although significant in the univariate analysis, age was not a significant predictor
of treatment success in the logistic regression model. The advantage of multivariable
analysis is the ability to examine several variables within a single study and account for
their potential interrelationship in the analysis of data.24 Using multivariable analysis,
we found that barriers to intervention recommendations and number of physical therapy
visits were most influential in predicting treatment success when age was held constant.
Our result is similar to Burgio35 who also found no relationship between age and
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treatment success using multivariable analysis. Consequently, age may not be a barrier to
a woman’s ability to respond to physical therapy.
Consumption of carbonated beverages is a risk factor for development of OAB.
Dallosso and colleagues found that women who consumed 2-6 carbonated beverages per
week had nearly a 50% increased risk for onset OAB (OR 1.44; 95% CI 1.12-1.185)
compared to those consuming <1 carbonated beverage per week.57 Thus, it is reasonable
to predict that women who consume more carbonated beverages may not achieve
favorable outcomes. The present study did not find a relationship between consumption
of carbonated beverages and outcomes. The manner that data were recorded may have
biased this result. The database was designed to require therapists to check a box for
patients who consumed ≥ 1 carbonated beverage weekly (database value of 1). If this
item was not completed, the database defaulted to a value of 0, indicating consumption of
<1 beverage weekly. Based on database design, there was no way to delineate if the
value was truly 0 (consumption of <1 carbonated beverage weekly) or if the value was
missing. In addition, the patient’s consumption of carbonated drinks was taken at
baseline. If the patient received education on carbonated beverage reduction, then the
patient may have decreased consumption by the end of treatment. Consequently, since
the risk factor (excessive consumption of carbonated beverages) was addressed during
treatment, it may not relate to treatment outcomes post-intervention. In future research
studies, it is important to consider if this item should be dropped or reprogrammed so
data will be valid and reliable.
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5.4 Treatments Received
This study is the first to describe treatment interventions for women with UI and
concomitant bowel symptoms, prolapse symptoms, and/or pelvic pain. Using a
pragmatic study design, we were able to obtain treatment information from 15 physical
therapists to capture what interventions women were receiving in true clinical situations.
The information will be presented to Centers for Rehab physical therapists and
administration for their interpretation and their decision on how they would use this
information for program quality improvement.
Nearly all (94%) of the women in this study received some type of patient
education. There was a trend for physical therapists to provide education on body
mechanics and relaxation techniques to women with pelvic pain. Patients with
lumbopelvic pain may demonstrate faulty posture and/or lifting techniques which, if not
corrected, may cause further injury to inert structures.210 Lifting with a neutral spine
posture provides greater stability of the spine and uses both the ligamentous and muscular
system for stabilization and control. Subsequently, education of body mechanics to
women with pelvic pain may help reduce chronic strain on the pelvic floor muscles186
which may improve pain symptoms. In addition, women with pelvic pain may
demonstrate pain and/or spasm of the pelvic floor muscles and relaxation training may
increase patient awareness and tension control over these muscles.210 In this study,
nearly 90% of women with pelvic pain (53/59) demonstrated spasm and pain of the
levator ani upon vaginal palpation. Of the women with levator ani muscle spasm, 71.7%
(38/53) received education in relaxation techniques. In a systematic review, relaxation
techniques, in combination with other interventions, were found to reduce pain for
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patients with chronic musculoskeletal pain.211 In addition, several case studies reported
decreased pain and levator ani tenderness for patients with pelvic pain receiving
multimodal interventions of relaxation techniques, manual physical therapy, and
exercise.165, 212 Thus, it appears that education of relaxation techniques, in combination
with other interventions, seems to be a reasonable way to address pain due to muscle
spasm. Centers for Rehab Services physical therapists included the education of
relaxation techniques for the majority of women with levator ani spasm and pain.
Physical therapists who did not incorporate education of relaxation techniques for women
with levator ani spasm may have instead selected equally effective interventions
including: education of soft tissue techniques, PFM downtraining, biofeedback for PFM
relaxation, or soft tissue mobilization.
We also examined if the distribution of selected treatment interventions was
consistent with evidence in the literature. Physical therapists indicated that they provided
education on the stress strategy for 51.9% of the women with SUI. The stress strategy, as
a single intervention, has been shown to be highly effective in reducing urine leakage in
women with mild SUI. Miller et al. reported a 98.2% reduction in urinary leakage for a
medium cough, and a 73.3% reduction for a deep cough when women with mild SUI
used the stress strategy. 73 Moreover, behavioral therapy including PFM exercise and the
stress strategy has been shown to reduce episodes of incontinence and improve quality of
life. 12, 16, 173, 182 Thus, it is surprising that the stress strategy was not included for a larger
proportion of women with SUI. However, out of the 26 women in the study that did not
receive education on the stress strategy, 9 women had spasm of the levator ani noted on
initial examination, and an additional 15 had symptoms of UUI. It is possible that
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physical therapists did not utilize the stress strategy for women with spasm of the levator
ani because contracting an already tightened muscle quickly and forcefully may actually
perpetuate the spasm. Of the 15 women with mixed UI (symptoms of SUI and UUI) who
did not receive education on stress strategy, 8 received urge suppression strategy
education. A common element of both urge and stress suppression techniques is
instructing the patient to contract her pelvic floor muscles to prevent UI when the
precipitating event occurs. The 8 patients who received urge suppression strategy
education may have automatically applied the PFM contraction to their stress symptoms
and consequently did indirectly receive education in preventing SUI episodes. However,
17% (9/54) of women with SUI did not receive any stress strategy education. Because
the stress strategy has been shown to be effective by itself 73 or as a component of
multimodal intervention trials,12, 16, 173, 182 a quality improvement initiative regarding this
discrepancy is recommended.
Seventy one percent of women included in this study that had UUI were taught
urge suppression strategies. Urge suppression strategies along with PFM exercise has
been shown to decrease UI episodes.75, 76, 142 Out of the 10 women with UUI that did not
receive education on urge suppression strategies, 2 had mixed UI and received education
on the stress strategy. Consequently, these 2 women may have applied the stress strategy
to automatically address their UUI symptoms and indirectly received education on urge
suppression techniques. Thus, 23% (8/35) of women with UUI did not receive education
on the urge suppression strategy. Because the urge suppression strategy has been shown
to be effective as part of a comprehensive treatment plan, a quality improvement
initiative regarding this discrepancy is recommended. However, it must be noted that 6 of
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the 8 women who did not receive education on urge suppression strategies were treated
with PFM downtraining. Physical therapists may have focused on downtraining in these
women, rather than repeated PFM contraction as in urge suppression, to promote
relaxation of PFM in an attempt to decrease urgency.
Sixty-eight percent (26/38) of women with constipation were educated to increase
fiber intake. Of the 32% (12/38) of women who did not receive this education, half
indicated at the initial examination they already included fiber in their diet. Subsequently,
it is possible that the physical therapist decided further fiber education was not necessary.
Evidence for increasing fiber intake to reduce constipation in women with constipation is
divided. One study found favorable results with supplementing participants’ diets with
high-fiber cereal.160 Alternately, a review of four studies that examined dietary fiber
intake by people with chronic constipation, found no differences compared to controls.159
In the present study, it appears that physical therapists are educating the majority of
women who lack appropriate fiber intake. Although evidence on increasing fiber intake
for constipation is inconclusive, it seems reasonable to suggest that women consume 2025 g of fiber daily as recommended by the National Academy of Sciences Institute of
Medicine to promote bowel health.160
Most (92.6%) of the women who indicated that they consumed excessive caffeine
were educated by physical therapists to reduce caffeine intake. This finding was
expected because of the common belief that caffeine worsens UI symptoms; however
little evidence exists to support this assumption. Although the stimulatory effect of
caffeine has been shown to directly influence the bladder by increasing bladder pressure
during filling,155 altering caffeine intake does not necessarily decrease UI symptoms.152
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For example, Dowd found no association between caffeine intake and UI episodes in 32
women >50 years.154 Conversely, Ayra and colleagues reported a significant association
between high caffeine intake (>400mg) and OAB.56 Despite conflicting evidence to
support caffeine restriction, it is clinically reasonable to educate patients to decrease
caffeine since excessive caffeine is a risk factor for OAB.
Recommendations to increase water intake was provided to 72% (31/43) of
women who consumed <3 glasses of water per day. It is recommend that adults consume
0.5 oz of water per lb of body weight/day.62 Drinking less than the recommended
amount may lead to concentrated and low-volume urine production. Subsequently,
inadequate water intake may lead to bladder irritation, urgency and frequency, urinary
tract infection and/or fecal impaction. Thus, it is surprising that 28% of women drinking
<3 glasses were not educated to increase water intake. However, the manner that data
were recorded may have biased this result. The database was designed to require
physical therapists to check a box for patients who consumed 3-6 or >6 glasses of water
per day. If this item was not completed, the database defaulted to the selection of <3
glasses of water per day and based on database design, there was no way to delineate if
the value was truly <3 glasses of water per day or if the value was missing. In future
research studies, it is important to consider reprogramming this item so data will be valid
and reliable.
Nearly all women in the study (98%) were prescribed PFM training. Because
PFM exercise has been shown to decrease UI episodes,11, 16-18, 23, 25, 70, 142-144 improve
quality of life,11, 18, 70, 144 and increase PFM strength for women with UI;11, 25, 70it appears
that Centers for Rehab Services physical therapists were consistent with the evidence in
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prescribing PFM exercise. There was more of a trend for physical therapists to elicit
PFM contraction with manual facilitation for women with bowel symptoms. Since 71%
(27/38) of women with constipation demonstrated PFM spasm upon vaginal palpation,
manual facilitation may have been used to confirm relaxation of the PFM after
contraction. In addition, it is possible that women with dual incontinence (urinary
incontinence and fecal incontinence) demonstrated weaker pelvic floor muscles. In the
present study, 50% (6/12) of women with dual incontinence demonstrated PFM atrophy
during vaginal palpation. Consequently, physical therapists may have decided that
manual facilitation was the most appropriate intervention to promote awareness of PFM
activity.
Over half of all women in the study (60%) were prescribed core stabilization
exercises. Because the percentages of women prescribed core stabilization were similar
across pelvic floor diagnoses, a Chi-square analysis was performed to determine if there
were differences in PGI-I defined success between women who were and were not
prescribed core stabilization exercises. Interestingly, women who received core training
were significantly more likely to obtain treatment success than woman who did not
perform core stabilization exercises. There is a growing body of evidence that suggests a
relationship between the function of the pelvic floor muscles and transverse abdominus
muscle. One study that included 6 healthy women and 1 man found that PFM EMG rose
above the resting level when a voluntary transverse abdominus contraction was
performed in the supine position. Interestingly, when these same subjects were asked to
perform a strong transverse abdominus contraction, levels of synergistic PFM activity
were similar to that observed when subjects were asked to perform a strong isolated

134

PFM contraction.151 Neumann and Gill149 and Sapsford150 also observed a synergistic
activation of the levator ani when healthy women performed a transverse abdominus
contraction in supine. In addition, the relationship between weak abdominal muscles and
the development of SUI has been discussed.71 Sapsford noted that during coughing and
nose-blowing, the abdominal wall of women with SUI bulges forward, especially when
they assume poor posture and fail to contract their abdominal muscles. In comparison,
healthy women pull their abdomen inward and contract their pelvic floor muscles during
a cough to increase intra-abdominal pressure to maintain continence.71, 150 The inclusion
of core strengthening or transverse abdominus exercises in the plan of care may have
contributed to women achieving PGI-I defined success. However, because the
intervention plans for women in our study were multimodal, conclusions regarding the
effectiveness of core stabilization exercises are limited. Women who achieved PGI-I
success may have received a different intervention other than core stabilization or a
combination of interventions that influenced PGI-I success.
Biofeedback and electrical stimulation to augment PFM exercises were prescribed
for only 13% and 12% of women, respectively. Based on the literature, PFM exercise
with biofeedback is not more efficacious than PFM exercise alone for women with SUI2325

or UUI.76, 144, 146 Likewise, investigations that compared electrical stimulation to PFM

exercise, or combined electrical stimulation and PFM exercise, have not shown superior
results to PFM exercise used alone.11, 16, 141 The use of adjunctive modalities for PFM
strengthening by physical therapists in this study was consistent with the scientific
evidence. Only a small percentage of women received biofeedback and electrical
stimulation. In some cases, the physical therapist may have only used these modalities
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for women who demonstrated difficulty performing PFM exercise due to very extreme
muscle weakness. Of the 13 women who received biofeedback for PFM strengthening,
over half (7/13) demonstrated levator ani atrophy upon physical therapy examination.
Similarly, 83% (10/13) of women who received electrical stimulation for PFM
strengthening demonstrated levator ani atrophy at initial examination.
Flexibility exercises of the lumbar spine and hip, joint mobilization, and soft
tissue mobilization were provided mostly to women with all 3 pelvic symptoms (urinary,
bowel, and pelvic pain). Physical therapists may have decided to utilize manual therapy
interventions to address common impairments that woman with pelvic pain possess
including restricted joint motion of the hip and/or pelvis;128 hypertonic PFM and/or
spasm of hip, lumbar or pelvic musculature;127, 130 and/or shortening of hip, low back or
pelvic muscles.132 In fact, 90.5% (49/54) and 31.5% (17/54) of women with all 3 pelvic
symptoms demonstrated levator ani muscle spasm and low back pain, respectively.
However, women with all 3 pelvic symptoms also received a significantly higher number
of mean physical therapy visits (8.92±5.72) compared to women without all 3 pelvic
symptoms (6.69±3.51) (p<0.020). Thus, because women with all 3 pelvic symptoms had
more visits, physical therapists may have had additional time/opportunity to implement
manual physical therapy and flexibility exercise interventions.
A major limitation of the study is that data entry may have been inconsistently
performed across physical therapists. In addition, it was assumed that physical therapists
entered information accurately. However, there is a chance that they did not enter the data
accurately. Additionally, they may have recorded an intervention(s) in the plan of care
but were not able to administer it because the patient did not return for follow-up visits.
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5.5 Conclusion
In our sample of convenience, physical therapy interventions provided within a
pragmatic setting significantly improved the pelvic symptoms and health-related quality
of life of women with a primary diagnosis of UI. Women’s global impression of
improvement was favorable, with sixty-six percent of women achieving the study criteria
for PGI-I treatment success. Patients without barriers to intervention recommendations
and patients who attended more physical therapy visits were more likely to attain PGI-I
defined success. Commonly used interventions for women in the study included patient
education on diet modification and relaxation techniques, PFM training, core stabilization
exercises, and manual physical therapy procedures.
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APPENDIX
Table A1.1: PFDI-20 and PFIQ-7 scores of study participants (Intention-to-treat
analysis)
Baseline
PFDI-20
(n=97)
PFIQ-7
(n=97)

87.95± 45.99

PostIntervention
67.77±48.15

Change Score
±SD
20.18±41.12

56.54±59.57

40.46±53.52

16.07±40.47

95% CI
11.8928.46
7.9324.21

tstatistic
4.833

pvalue
0.000

3.921

0.000

Table A1.2 (a-c): Relationships between dichotomous independent variables and PFDI20 and PFIQ-7 mean change scores
Table A1.2a: Comparison of mean PFDI-20 and PFIQ-7 change scores when subjects are
divided based on parity
Parity=No
Parity=1 or
Mean
95% CI
tpdeliveries
more
difference
statistic value
deliveries
±SD
PFDI-20
-18.43±19.38 -41.30±51.90 -22.88±19.96 -17.201.146
0.257
change
(n=7)
(n=46)
62.95
score
(n=53)
PFIQ-7
-39.14±28.41 -29.73±54.30 -9.42±21.09 -51.80- -0.466 0.657
change
(n=7)
(n=44)
32.97
score
(n=51)
Table A1.2b: Comparison of mean PFDI-20 and PFIQ-7 change scores when subjects
are divided based on presence of barriers
No barriers
1 or more
Mean
95% CI
tpbarriers
difference
statistic value
±SD
PFDI-20
-41.00±44.08 -24.20±67.69 -16.80±17.16 -51.24- - 0.979 0.332
change
(n=44)
(n=10)
17.64
score
(n=54)
PFIQ-7
-29.14±48.46 -34.90±64.65
5.76±18.18
-30.760.317 0.753
change
(n=42)
(n=10)
42.27
score
(n=52)
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Table A1.2c: Comparison of mean PFDI-20 and PFIQ-7 change scores when subjects are
divided based on parity consumption of carbonated beverages

PFDI-20
change
score
(n=54)
PFIQ-7
change
score
(n=52)

<1
carbonated
beverage /
week

≥1
carbonated
beverage /
week

Mean
difference
±SD

95% CI

tstatistic

pvalue

-39.80± 51.37
(n=46)

-26.88±32.09
(n=8)

-12.93±18.85

-50.7624.90

- 0.686

0.316

-30.93±54.28
(n=81)

-25.86±25.73
(n=16)

-5.08±21.00

-47.2637.11

- 0.242

0.810

Table A1.3: Correlations between independent variables of age, number of physical
therapy visits and number of comorbidities and PFDI-20/PFIQ-7 change
scores
Age
PFDI-20
change score
(n=54)
PFIQ-7
change score
(n=52)

r
0.167
- 0.005

p-value
0.227
0.975

Number of physical
therapy visits
r
p-value
- 0.153
0.273

Number of
comorbidities
r
p-value
-0.105
0.448

- 0.178

-0.009
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0.211

0.950

Table A1.4: Comparison of mean age, number of physical therapy visits and number of
comorbidities when subjects are divided based on PGI-I success/failure

Age
Number of
physical
therapy
visits
Number of
comorbidities
*p<0.10

PGI-I
Success
(n=66)
51.86±15.59

PGI-I
Failure
(n=34)
59.29±13.15

Mean
difference
±SD
7.43±3.127

9.05±5.51

5.74±2.55

- 3.31±0.82

2.25±1.23

2.18±1.11

0.066±.251

95% CI

tstatistic

pvalue

1.2213.64
- 4.93-1.69

2.376

0.019*

-0.5650.433

- 4.06

0.000*

- 0.262

0.794

Table A1.5 (a-b): Relationships between dichotomous variables and PGI-I
success/failure
Table A1.5a: Parity
PGI-I Success
Nulliparous
10 (10.2%)
Parous
54 (55.1%)
Total
64 (65.3%)
Fisher’s Exact Test p-value=0.782

PGI Failure
6 (6.1%)
28 (28.6%)
34 (34.7%)

Total
16 (16.3%)
82 (83.7%)
100 (100%)

Table A1.5b: Carbonated Beverage
<1 carbonated beverage / week
≥1 carbonated beverage / week
Total
Fisher’s Exact Test p-value=0.778

PGI-I Success

PGI-I Failure

Total

56 (56%)
10 (10%)
66 (66%)

28 (28%)
6 (6%)
34 (34%)

84 (84%)
16 (16%)
100 (100%)
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